(19)
(11)EP 2 652 014 B1

(12)EUROPEAN PATENT SPECIFICATION

(45)Mention of the grant of the patent:
01.07.2020 Bulletin 2020/27

(21)Application number: 11806047.4

(22)Date of filing:  12.12.2011
(51)Int. Cl.: 
C08J 3/20  (2006.01)
(86)International application number:
PCT/US2011/064320
(87)International publication number:
WO 2012/082578 (21.06.2012 Gazette  2012/25)

(54)

PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING

VERARBEITUNG VON ZUSATZSTOFFEN UND DEREN VERWENDUNG BEIM ROTATIONSGIESSEN

ADDITIFS DE TRAITEMENT ET LEURS UTILISATIONS EN MOULAGE PAR ROTATION


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 13.12.2010 US 422255 P

(43)Date of publication of application:
23.10.2013 Bulletin 2013/43

(73)Proprietor: Cytec Technology Corp.
Wilmington, DE 19801 (US)

(72)Inventors:
  • SAMUELS, Sari-Beth
    Ramsey, NJ 07446 (US)
  • STEELE, Thomas
    Milford, CT 06460 (US)
  • ENG, J. Mon, Hei
    Wilton, CT 06897 (US)
  • GUPTA, Ram
    Stamford, CT 06902 (US)
  • PENG, Lingqing
    Pudong District 200136 Shanghai (CN)

(74)Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56)References cited: : 
EP-A1- 0 839 623
WO-A1-90/07547
US-A1- 2009 085 252
EP-A1- 2 014 704
US-A1- 2006 167 146
  
      
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


    Description

    BACKGROUND OF THE INVENTION


    1. Field of the Invention



    [0001] The present invention generally relates to the production of hollow articles using the rotational molding process. More particularly, the present invention relates to the additives described hereinbelow and their use in such processes to improve molding cycle time (i.e., reducing curing time) while maintaining process stability over a broader range of temperatures.

    2. Description of the Related Art



    [0002] Rotational molding, or rotomolding, is a high-temperature, low-pressure forming process that uses heat and biaxial rotation to produce hollow, one-piece parts, typically made of plastic. Such plastic hollow parts typically made by a rotomolding process include, for example, gasoline containers, garbage cans, agricultural storage vessels, septic tanks, toys, and sporting goods such as kayaks.

    [0003] The process is undertaken by loading a charge of finely divided plastic resin into the mold "shell", then rotating the mold (usually, on two axes) while heating it to a temperature above the melting point of the plastic resin. The melted plastic flows through the mold cavity under the forces caused by the rotation of the apparatus. The rotation continues for sufficient time to allow the molten plastic to cover the surface of the mold. The mold is then cooled to permit the plastic to freeze into a solid. The final stage of the molding cycle is the removal of the part from the rotomolding machine.

    [0004] The time required to complete the molding cycle is a function of the bulk properties of the plastic which is being molded. For example, it is recognized by those skilled in the art that the plastic resin which is charged into the mold is preferably finely divided (i.e. ground into powder) and has a high bulk density and a narrow particle size distribution to facilitate the "free flow" of the resin.

    [0005] It will also be appreciated that the physical properties of the rotomolded part are influenced by the use of a proper molding cycle time with "undercooked" parts having poor strength properties and "overcooked" parts suffering from poor appearance (a "burnt" color) and/or a deterioration of strength properties. It is desirable to have a short molding cycle (so as to improve the productivity of the expensive rotomolding machinery) and a broad processing window. Thus, the rotomolding composition ideally provides "properly cooked" parts in a short period of time but does not become "overcooked" for an extended period of time.

    [0006] Therefore, the length of time the resin-filled mold spends in the oven is critical, because if left too long the polymer will yellow and/or degrade, thereby negatively affecting the mechanical and/or physical properties of the molded article (e.g., reducing impact strength). If the time the resin filled mold spends in the oven is too short, the scintering and laydown of the molten polymer will be incomplete, thereby negatively affecting the final physical and/or mechanical properties of the molded article. Thus, there is only a narrow temperature and/or time range for achieving the desired mechanical and/or physical properties of the molded article (i.e., processing window). Accordingly, it would be advantageous to widen/broaden this processing window so that parts that have been processed with longer oven cycle times will still exhibit optimal mechanical and/or physical properties.

    [0007] Various additives are known and have been used in the rotomolding process to stabilize the polyolefin material and effectively reduce the production of microstructural defects during the heating cycle of the rotomolding process, which negatively affect the molded article. Some of these additives are also known to affect the cycle time of the rotomolding process. See, e.g., Botkin et al., 2004 "An additive approach to cycle time reduction in rotational molding," Society of Plastics Engineers Rotomolding Conference; Session 2. For example, the use of stabilizer combinations of phosphites or phosphonites with sterically hindered phenols in polyolefins is generally known. Such phenolic/phosphite or phosphonite blends (e.g., CYANOX® 2777 antioxidant (available from Cytec Industries Inc., Woodland Park NJ)) will stabilize the resin in the oven for a longer time (resulting in a broader process window), but requires a longer time in the oven to achieve maximum physical properties (resulting in a longer cycle time). Other stabilizer compositions (e.g., hydroxylamine derivatives blended with phosphites and/or phosphonites and HALS), allow for faster polymerization and cure times of the resins, but the processing window remains very narrow. For example, improvements to widen the processing window by using sterically hindered amines are disclosed in US Publication No. 2009/0085252.

    [0008] Accordingly, the rotational molding of polyolefin resins requires further improvements in cycle time reduction. A stabilizer composition that effectively reduces the time for scintering and laydown of the polymer melt (with reduced oven cycle time), while maintaining a broad processing window, would be a useful advance in the field, and would find rapid acceptance in the rotational molding industry. Shorter cycle times would lead to greater production yield, higher production efficiency, and, thus, lower energy uses. Formulations exhibiting a broadened process window would be easier to fabricate, without concerns about overcuring and the potential for deterioration of the mechanical properties of the resulting part. Further, formulations exhibiting both a broadened process window and shorter cycle time would enable molders to fabricate parts of different thickness at the same time, thereby further enhancing productivity.

    SUMMARY OF THE INVENTION



    [0009] The discovery described in detail hereinbelow provides stabilizer compositions and processes for using same for reducing cycle time without compromising the processing window in rotational molding processes related to polyolefin articles. These stabilizer compositions and processes effectively reduce the time in the oven needed to reach optimal physical and/or mechanical properties, thereby reducing cycle times of the rotomolding process and consequently increasing production yield and production efficiency, and lowering energy requirements.

    [0010] Accordingly, in one aspect the invention provides a process for reducing cycle time and/or maintaining a broad process window in a rotational molding process for producing a polymeric hollow article, by subjecting a polymer composition and a polymer-stabilizing amount of a stabilizer composition to a rotational molding process, wherein the stabilizer composition includes:
    1. i) at least one chroman-based compound according to Formula V

      wherein

      R21 is a substituent that can be the same or different at from 0 to 4 positions of the aromatic portion of Formula V and is independently chosen from:

      C1-C12 hydrocarbyl;

      NR'R", wherein each of R' and R" is independently chosen from H and C1-C12 hydrocarbyl; and

      OR27, wherein R27 is chosen from: H; C1-C12 hydrocarbyl; COR'''; and Si(R28)3, wherein R''' is chosen from H and C1-C20 hydrocarbyl; and wherein R28 is chosen from C1-C12 hydrocarbyl and alkoxy;

      R22 is chosen from: H; and C1-C12 hydrocarbyl;

      R23 is chosen from H; and C1-C20 hydrocarbyl; and

      each of R24-R25 is independently chosen from: H; C1-C12 hydrocarbyl; and OR"", wherein R"" is chosen from H and C1-C12 hydrocarbyl; and

      R26 is H, or a bond which together with R25 forms =O.



    [0011] In another aspect, the invention provides processes for producing a polymeric hollow article, by a) filling a mold with a polymer composition and a polymer-stabilizing amount of a stabilizer composition including at least one chroman-based compound according to Formula V (as described above), b) rotating the mold around at least 1 axis while heating the mold in an oven, thereby fusing the composition and spreading it to the walls of the mold; c) cooling the mold; and d) opening the mold to remove the resulting product, thereby producing a polymeric hollow article.

    [0012] In another aspect, the invention provides a stabilizer composition having:
    1. a) at least one compound chosen from the group of organic phosphites and phosphonites;
    2. b) at least one hindered phenol compound; and
    3. c) from 0.001 to 5 % by weight of the total of at least one chroman-based compound according to Formula V (as described above).


    [0013] In another aspect, the invention provides a stabilizer composition consisting of
    1. a) at least one compound chosen from the group of organic phosphites and phosphonites;
    2. b) at least one hindered phenol compound; and
    3. c) at least one chroman-based compound according to Formula V (as described above).


    [0014] In still other aspects, the invention provides kits for stabilizing a polyolefin composition for use in a rotomolding process including in one or more containers a polymer-stabilizing amount of a stabilizer composition as described herein, as well as provides rotomolded articles that are produced according to the processes described herein, or that contain a stabilizer composition as described herein.

    [0015] These and other objects, features and advantages of this invention will become apparent from the following detailed description of the various aspects of the invention taken in conjunction with the accompanying Figures and Examples.

    BRIEF DESCRIPTION OF THE DRAWINGS



    [0016] 

    FIG. 1 illustrates the mean failure energy (MFE) of rotomolded parts made with control stabilizer system (◆) vs. low phenolic stabilizer system (▲) vs. a processing stabilizer system according to the invention (■). As seen, the rotomolded part that was formulated with the stabilizer system according to the invention (■) achieves the highest MFE (as determined by the Dart Drop Low Temperature Impact Resistance Test Procedure) at a shorter rotational molding time interval (given by peak internal air temperature) compared to the rotomolded part that was formulated with either the control stabilizer system (◆) or the low phenolic stabilizer system (A). Furthermore, the rotomolded part formulated according to the invention unexpectedly retains a higher MFE at longer oven times than do the rotomolded parts formulated with either the control or low phenolic stabilizer systems. Accordingly, the benefit of using a processing stabilizer according to the invention in a rotational molding process is due to the use of a chroman-based compound and not due to use of a lower amount of phenolic/phosphite.

    FIGS. 2A-B illustrate the MFE of 1/4" rotomolded parts made with control stabilizer (◆) and stabilizer system according to the invention (■) in a LLDPE resin provided by a particular supplier (Resin 1), and the Yellowness Index of the same rotomolded parts as a function of peak internal air temperature.

    FIGS. 3A-B illustrate the MFE of 1/4" rotomolded parts made with control/state-of-the-art stabilizer (◆); stabilizer system according to the invention (■); and a second control/state-of-the-art stabilizer (▲) in a LLDPE resin provided by a different supplier (Resin 2), and the Yellowness Index of the same rotomolded parts as a function of peak internal air temperature.


    DETAILED DESCRIPTION OF CERTAIN EMBODIMENTS OF THE INVENTION



    [0017] As summarized above, the compositions and processes using same that have now been discovered and disclosed herein for the first time are surprisingly useful for achieving optimal physical and/or mechanical properties of a rotomolded hollow article in a shorter period of time in the oven (i.e., cycle time) compared to those rotomolded articles made with current commercially available polymer stabilizer packages. Furthermore, the processes and compositions disclosed herein additionally (and surprisingly) provide a wider/broader processing window within which the desired final properties of the rotomolded article can be obtained before the physical and/or mechanical properties are negatively affected.

    Definitions



    [0018] As employed above and throughout the disclosure, the following terms are provided to assist the reader. Unless otherwise defined, all terms of art, notations and other scientific terminology used herein are intended to have the meanings commonly understood by those of skill in the chemical arts. As used herein and in the appended claims, the singular forms include plural referents unless the context clearly dictates otherwise.

    [0019] Throughout this specification the terms and substituents retain their definitions. A comprehensive list of abbreviations utilized by organic chemists (i.e. persons of ordinary skill in the art) appears in the first issue of each volume of the Journal of Organic Chemistry. The list, which is typically presented in a table entitled "Standard List of Abbreviations" is incorporated herein by reference.

    [0020] The term "hydrocarbyl" is a generic term encompassing aliphatic, alicyclic and aromatic groups having an all-carbon backbone and consisting of carbon and hydrogen atoms. In certain cases, as defined herein, one or more of the carbon atoms making up the carbon backbone may be replaced or interrupted by a specified atom or group of atoms, such as by one or more heteroatom of N, O, and/or S. Examples of hydrocarbyl groups include alkyl, cycloalkyl, cycloalkenyl, carbocyclic aryl, alkenyl, alkynyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkenylalkyl, and carbocyclic aralkyl, alkaryl, aralkenyl and aralkynyl groups. Such hydrocarbyl groups can also be optionally substituted by one or more substituents as defined herein. Accordingly, the chemical groups or moieties discussed in the specification and claims should be understood to include the substituted or unsubstituted forms. The examples and preferences expressed below also apply to each of the hydrocarbyl substituent groups or hydrocarbyl-containing substituent groups referred to in the various definitions of substituents for compounds of the formulas described herein unless the context indicates otherwise.

    [0021] Preferred non-aromatic hydrocarbyl groups are saturated groups such as alkyl and cycloalkyl groups. Generally, and by way of example, the hydrocarbyl groups can have up to fifty carbon atoms, unless the context requires otherwise. Hydrocarbyl groups with from 1 to 30 carbon atoms are preferred. Within the sub-set of hydrocarbyl groups having 1 to 30 carbon atoms, particular examples are C1-20 hydrocarbyl groups, such as C1-12 hydrocarbyl groups (e.g. C1-6 hydrocarbyl groups or C1-4 hydrocarbyl groups), specific examples being any individual value or combination of values selected from C1 through C30 hydrocarbyl groups.

    [0022] Alkyl is intended to include linear, branched, or cyclic hydrocarbon structures and combinations thereof. Lower alkyl refers to alkyl groups of from 1 to 6 carbon atoms. Examples of lower alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, s-and t-butyl and the like. Preferred alkyl groups are those of C30 or below.

    [0023] Alkoxy or alkoxyalkyl refers to groups of from 1 to 20 carbon atoms of a straight, branched, cyclic configuration and combinations thereof attached to the parent structure through an oxygen. Examples include methoxy, ethoxy, propoxy, isopropoxy, cyclopropyloxy, cyclohexyloxy and the like.

    [0024] Acyl refers to formyl and to groups of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 carbon atoms of a straight, branched, cyclic configuration, saturated, unsaturated and aromatic and combinations thereof, attached to the parent structure through a carbonyl functionality. Examples include acetyl, benzoyl, propionyl, isobutyryl, t-butoxycarbonyl, benzyloxycarbonyl and the like. Lower-acyl refers to groups containing one to six carbons.

    [0025] References to "carbocyclic" or "cycloalkyl" groups as used herein shall, unless the context indicates otherwise, include both aromatic and non-aromatic ring systems. Thus, for example, the term includes within its scope aromatic, non-aromatic, unsaturated, partially saturated and fully saturated carbocyclic ring systems. In general, such groups may be monocyclic or bicyclic and may contain, for example, 3 to 12 ring members, more usually 5 to 10 ring members. Examples of monocyclic groups are groups containing 3, 4, 5, 6, 7, and 8 ring members, more usually 3 to 7, and preferably 5 or 6 ring members. Examples of bicyclic groups are those containing 8, 9, 10, 11 and 12 ring members, and more usually 9 or 10 ring members. Examples of non-aromatic carbocycle/cycloalkyl groups include c-propyl, c-butyl, c-pentyl, c-hexyl, and the like. Examples of C7 to C10 polycyclic hydrocarbons include ring systems such as norbornyl and adamantyl.

    [0026] Aryl (carbocyclic aryl) refers to a 5- or 6-membered aromatic carbocycle ring. containing; a bicyclic 9- or 10-membered aromatic ring system; or a tricyclic 13- or 14-membered aromatic ring system. The aromatic 6- to 14-membered carbocyclic rings include, e.g., substituted or unsubstituted phenyl groups, benzene, naphthalene, indane, tetralin, and fluorene.

    [0027] Substituted hydrocarbyl, alkyl, aryl, cycloalkyl, alkoxy, etc. refer to the specific substituent wherein up to three H atoms in each residue are replaced with alkyl, halogen, haloalkyl, hydroxy, alkoxy, carboxy, carboalkoxy (also referred to as alkoxycarbonyl), carboxamido (also referred to as alkylaminocarbonyl), cyano, carbonyl, nitro, amino, alkylamino, dialkylamino, mercapto, alkylthio, sulfoxide, sulfone, acylamino, amidino, phenyl, benzyl, halobenzyl, heteroaryl, phenoxy, benzyloxy, heteroaryloxy, benzoyl, halobenzoyl, or loweralkylhydroxy.

    [0028] The term "halogen" means fluorine, chlorine, bromine or iodine.

    [0029] As used herein, the term "chroman-based compound" refers to those compounds having a functional chroman group as part of the compound. In certain embodiments the chroman-based compound will be substituted. In other embodiments, the chroman-based compound can include chromanones. Coumarin and tocotrienols are specific examples of chroman-based compounds.

    [0030] The terms "cycle time" or "molding cycle" as used herein are given their ordinary meaning as commonly understood by those of skill in the rotomolding arts and refer to the time from one point in the cycle to the corresponding point in the next repeated sequence (i.e., the time required to produce a plastic part in a molding operation as measured from a point of one operation to the same point of the first repeat of the operation).

    [0031] The terms "optimal mechanical property" or "optimal physical property" as used herein refer to rotomolded parts having the most desirable: impact strength, coalescence or scintering of polymer particles, and general appearance such as color.

    [0032] All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term "about." Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.

    Processes



    [0033] Rotational molding technology is well known and described in the literature. Many aspects of the rotational molding process are described, for example, by R. J. Crawford and J. L. Throne in Rotational Molding Technology, Plastics Design Library, William Andrew Publishing, 2001. The rotomolded articles described herein are made from stabilized polymer compositions according to the invention using rotational molding techniques generally accepted by those skilled in the art as being representative of commercial rotational molding processes. In general, these rotational molding techniques involve the use of a rotational mold and an oven. A polymer composition (e.g., a stabilized polymer composition including a stabilizer composition and a polymer composition as described herein) is placed in a mold possessing a predetermined shape. The mold is heated within the oven at a predetermined rate to a peak temperature. During heating, the resin melts and the mold is rotated in two or three dimensions to ensure that the melted resin evenly coats the interior surfaces of the mold. Optionally, the melted resin may be cured for a predetermined time. After heating is complete, the mold is removed from the oven and cooled (with the mold optionally being in rotation). Once cool, the formed plastic part is removed from the mold.

    [0034] Surprisingly, it has now been found that when at least one chroman-based compound is added to the rotomolding resin formulation the time at which it takes to reach peak internal air temperature (PIAT) is reduced and a significantly broader processing window towards higher temperatures is achieved without adversely affecting the physical and/or mechanical properties of the molded article.

    [0035] Consequently, in one aspect the invention provides a process for reducing cycle time while maintaining an enlarged process window in a rotational molding process for producing a polymeric hollow article by subjecting a polymer composition and a polymer-stabilizing amount of a stabilizer composition to a rotational molding process, wherein the stabilizer composition includes at least one chroman-based compound according to Formula V as described herein.

    [0036] In certain embodiments, the cycle time of the process will be reduced by at least 4 %, at least 5 %, at least 10 %, at least 15 %, or at least 20 %, at least 25 %, at least 40 %, or at least 50 % as compared to a process that does not include at least one chroman-based compound in the resin formulation.

    [0037] In another aspect, the invention provides a process for producing a polymeric hollow article by a) filling a mold with a polymer composition and a polymer-stabilizing amount of a stabilizer composition, wherein the stabilizer composition includes at least one chroman-based compound according to Formula V as described herein; b) rotating the mold around at least one axis while heating the mold in an oven, thereby fusing the composition and spreading it to the walls of the mold; c) cooling the mold; and d) opening the mold to remove the resulting product, thereby producing a polymeric hollow article.

    [0038] During the rotomolding process, the temperature of the oven can reach from 70 °C to 400 °C, preferably from 280 °C to 400 °C, and more preferably from 310 °C to 400 °C.

    [0039] The stabilized polymer compositions suitable for use with the aforementioned processes are further described below.

    Stabilized Polymer Compositions



    [0040] The stabilizer compositions according to the invention and suitable for use with the polymer compositions for the rotomolding processes as described herein include at least one chroman-based compound according to Formula V:

    wherein

    R21 is a substituent that can be the same or different at from 0 to 4 positions of the aromatic portion of Formula V and is independently chosen from:

    C1-C12 hydrocarbyl;

    NR'R", wherein each of R' and R" is independently chosen from H and C1-C12 hydrocarbyl; and

    OR27, wherein R27 is chosen from: H; C1-C12 hydrocarbyl; COR'''; and Si(R28)3, wherein R''' is chosen from H and C1-C20 hydrocarbyl; and wherein R28 is chosen from C1-C12 hydrocarbyl and alkoxy;

    R22 is chosen from: H; and C1-C12 hydrocarbyl;

    R23 is chosen from H; and C1-C20 hydrocarbyl; and

    each of R24-R25 is independently chosen from: H; C1-C12 hydrocarbyl; and OR"", wherein R"" is chosen from H and C1-C12 hydrocarbyl; and

    R26 is H, or a bond which together with R25 forms =O.



    [0041] In certain embodiments, R21 is present as hydroxyl and methyl. In other embodiments, R21 is present as acyl and methyl.

    [0042] In certain embodiments, R23 is a C1-C18 hydrocarbyl.

    [0043] In some embodiments, the chroman-based compound according to Formula V is a tocotrienol, including, but not limited to, α-tocotrienol; β-tocotrienol; γ-tocotrienol, and δ-tocotrienol. In other embodiments, the chroman-based compound is a tocopherol including, but not limited to, α-tocopherol, β-tocopherol, γ-tocopherol, and δ-tocopherol.

    [0044] In some embodiments, the chroman-based compound is vitamin E or its acetate according to Formula Va

    wherein R21 is chosen from OH; and -OC(O)CH3, respectively.

    [0045] In certain embodiments, the stabilizer composition includes two or more chroman-based compounds according to Formula V.

    [0046] The chroman-based compound is present from 0.001 to 5.0 % by weight of the total weight of the stabilizer composition, preferably from 0.01 to 2.0 % by weight of the total weight of the stabilizer composition, and more preferably from 0.01 to 1.0 % by weight of the total weight of the stabilizer composition. In certain embodiments, the chroman-based compound is present at 0.05 % by weight of the total weight of the stabilizer composition.

    [0047] In certain embodiments, the stabilizer composition can further include at least one compound chosen from the group of organic phosphites or phosphonites. In some embodiments the organic phosphite or phosphonite compound includes at least one organic phosphite or phosphonite chosen from a compound according to Formulas 1-7:













    in which the indices are integral and

    n is 2, 3 or 4; p is 1 or 2; q is 2 or 3; r is 4 to 12; y is 1, 2 or 3; and z is 1 to 6;

    A1, if n is 2, is C2-C18 alkylene; C2-C12 alkylene interrupted by oxygen, sulfur or -NR4-; a radical of the formula

    or phenylene;

    A1, if n is 3, is a radical of the formula -CrH2r-1-;

    A1, if n is 4, is

    A2 is as defined for A1 if n is 2;

    B is a direct bond, -CH2-, -CHR4-, -CR1R4-, sulfur, C5-C7 cycloalkylidene, or cyclohexylidene which is substituted by from 1 to 4 C1-C4 alkyl radicals in position 3, 4 and/or 5;

    D1, if p is 1, is C1-C4 alkyl and, if p is 2, is -CH2OCH2-;

    D2, if p is 1, is C1-C4 alkyl;

    E, if y is 1, is C1-C18 alkyl, -OR1 or halogen;

    E, if y is 2, is -O-A2-O-,

    E, if y is 3, is a radical of the formula R4C(CH2O-)3 or N(CH2CH2O-)3;

    Q is the radical of an at least z-valent alcohol or phenol, this radical being attached via the oxygen atom to the phosphorus atom;

    R1, R2 and R3 independently of one another are C1-C18 alkyl which is unsubstituted or substituted by halogen, -COOR4, -CN or -CONR4R4; C2-C18 alkyl interrupted by oxygen, sulfur or -NR4-; C7-C9 phenylalkyl; C5-C12 cycloalkyl, phenyl or naphthyl; naphthyl or phenyl substituted by halogen, 1 to 3 alkyl radicals or alkoxy radicals having a total of 1 to 18 carbon atoms or by C7-C9 phenylalkyl; or a radical of the formula

    in which m is an integer from the range 3 to 6;

    R4 is hydrogen, C1-C8 alkyl, C5-C12 cycloalkyl or C7-C9 phenylalkyl,

    R5 and R6 independently of one another are hydrogen, C1-C8 alkyl or C5-C6 cycloalkyl,

    R7 and R8, if q is 2, independently of one another are C1-C4 alkyl or together are a 2,3-dehydropentamethylene radical; and

    R7 and R8, if q is 3, are methyl;

    R14 is hydrogen, C1-C9 alkyl or cyclohexyl,

    R15 is hydrogen or methyl and, if two or more radicals R14 and R15 are present, these radicals are identical or different,

    X and Y are each a direct bond or oxygen,

    Z is a direct bond, methylene, -C(R16)2- or sulfur, and

    R16 is C1-C8 alkyl;

    a trisarylphosphite according to Formula 8:

    wherein R17 is a substituent that is the same or different at from 0 to 5 positions of the aromatic portion of Formula 8 and is independently chosen from C1-C20 alkyl, C3-C20 cycloalkyl, C4-C20 alkyl cycloalkyl, C6-C10 aryl, and C7-C20 alkylaryl; and combinations thereof.

    [0048] In some embodiments, the following organic phosphites or phosphonites are preferred: triphenyl phosphite; diphenyl alkyl phosphites; phenyl dialkyl phosphites; trilauryl phosphite; trioctadecyl phosphite; distearyl pentaerythritol phosphite; tris(2,4-di-tert-butylphenyl) phosphite; tris(nonylphenyl) phosphite; a compound of formulae (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) and (L):





















    2-butyl-2-ethyl-1,3-propanediol 2,4,6-tri-t-butylphenol phosphite; bis-(2,6-di-t-butyl-4-methlphenyl) pentaerythritol diphosphite; 2-butyl-2-ethyl-1,3-propanediol 2,4-di-cumyiphenol phosphite; 2-butyl-2-ethyl-1,3-propanediol 4-methyl-2,6-di-t-butylphenol phosphite; and bis-(2,4,6-tri-t-butyl-phenyl) pentaerythritol diphosphite.

    [0049] The following organic phosphites and phosphonites are particularly suitable for use in the rotomolding processes described herein: tris(2,4-di-tert-butylphenyl)phosphite (IRGAFOS® 168); Bis(2,4-dicumylphenyl)pentaerythritol diphosphite (DOVERPHOS® S9228); and tetrakis(2,4-di-tert-butylphenyl)4,4'-biphenylene-diphosphonite (IRGAFOS® P-EPQ).

    [0050] The organic phosphites or phosphonites can be present in an amount from 0.01 % to 10 % by weight based on the total weight of the polymer material to be stabilized. Preferably, the amount of organic phosphite or phosphonite is available from 0.05 to 5 %, and more preferably from 0.1 to 3 % by weight based on the total weight of the polymer material to be stabilized.

    [0051] In certain embodiments, the stabilizer composition can further include at least one hindered phenol compound. Suitable hindered phenols for use with the rotomolding processes described herein include, but are not limited to, those having a molecular fragment according to one or more of Formula (IVa), (IVb), or (IVc):

    wherein "

    " indicates the point of attachment (via a carbon bond) of the molecular fragment to a parent compound, and wherein R18 is chosen from hydrogen and a C1-4 hydrocarbyl; R19 and R20 are the same or different and are independently chosen from hydrogen and a C1-C20 hydrocarbyl; and R37 is chosen from a C1-C12 hydrocarbyl. In some embodiments, R18 and R37 are independently chosen from methyl and t-butyl.

    [0052] The following compounds exemplify some hindered phenols that are suitable for use in the compositions and processes of the invention: (1,3,5-Tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione; 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazirie-2,4,6(1H,3H,5H)-trione (IRGANOX® 3114); 1,1,3-Tris(2'-methyl-4'-hydroxy-5'-t-butylphenyl)butane; Triethylene glycol bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionate]; 4,4'-Thiobis(2-t-butyl-5-methylphenol); 2,2'-Thiodiethylene bis[3-(3-t-butyl-4-hydroxyl-5-methylphenyl)propionate]; Octadecyl 3-(3'-t-butyl-4'-hydroxy-5'-methylphenyl)propionate; Tetrakismethylene(3-t-butyl-4-hydroxy-5-methylhydrocinnamate)methane; N,N'-Hexamethylene bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionamide]; Di(4-tertiarybutyl-3-hydroxy-2,6-dimethyl benzyl) thiodipropionate; and octadecyl 3,5-di-(tert)-butyl-4-hydroxyhydrocinnamate.

    [0053] Other phenols also suitable for use with processes and compositions of the invention are known to those of skill in the art and include, for example:

    2,6-di-tert-butyl-4-methylphenol; 2-tert-butyl-4,6-dimethylphenol; 2,6-di-tert-butyl-4-ethylphenol; 2,6-di-tert-butyl-4-n-butylphenol; 2,6-di-tert-butyl-4 isobutylphenol; 2,6-dicyclopentyl-4-methylphenol; 2-(α-methylcyclohexyl)-4,6 dimethylphenol; 2,6-di-octadecyl-4-methylphenol; 2,4,6,-tricyclohexyphenol; and 2,6-di-tert-butyl-4-methoxymethylphenol;

    2,2'-methylene-bis-(6-tert-butyl-4-methylphenol) (CYANOX® 2246); 2,2'-methylene-bis-(6-tert-butyl-4-ethylphenol) (CYANOX® 425); 2,2'-methylene-bis-(4-methyl-6-(α-methylcyclohexyl)phenol); 2,2'-methylene-bis-(4-methyl-6-cyclohexylphenol); 2,2'-methylene-bis-(6-nonyl-4-methylphenol); 2,2'-methylene-bis-(6-nonyl-4methylphenol); 2,2'-methylene-bis-(6-(α-methylbenzyl)-4-nonylphenol); 2,2'-methylene-bis-(6-(α,α-dimethylbenzyl)-4-nonyl-phenol); 2,2'-methylene-bis-(4,6-di-tert-butylphenol); 2,2'-ethylidene-bis-(6-tert-butyl-4-isobutylphenol); 4,4'methylene-bis-(2,6-di-tert-butylphenol); 4,4'-methylene-bis-(6-tert-butyl-2-methylphenol); 1,1-bis-(5-tert-butyl-4-hydroxy-2-methylphenol)butane 2,6-di-(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol; 1,1,3-tris-(5-tert-butyl-4-hydroxy-2-methylphenyl)butane; 1,1-bis-(5-tert-butyl-4-hydroxy2-methylphenyl)-3-dodecyl-mercaptobutane; ethyleneglycol-bis-(3,3,-bis-(3'-tert-butyl-4'-hydroxyphenyl)-butyrate)-di-(3-tert-butyl-4-hydroxy-5-methylpenyl)-dicyclopentadiene; di-(2-(3'-tert-butyl-2'hydroxy-5'methylbenzyl)-6-tert-butyl-4-methylpheny-l)terephthalate; and other phenolics such as monoacrylate esters of bisphenols such as ethylidiene bis-2,4-di-t-butylphenol monoacrylate ester;

    Hydroquinones such as 2,6-di-tert-butyl-4-methoxyphenol; 2,5-di-tert-butylhydroquinone; 2,5-di-tert-amyl-hydroquinone; and 2,6-diphenyl-4-octadecyloxyphenol; and

    Thiodiphenyl ethers such as 2,2'-thio-bis-(6-tert-butyl-4-methylphenol); 2,2'-thio-bis-(4-octylphenol); 4,4'thio-bis-(6-tert-butyl-3-methylphenol); and 4,4'-thio-bis-(6-tert-butyl-2-methylphenol).



    [0054] A stabilizer composition including at least one chroman-based compound according to Formula V is suitable for stabilizing polyolefin hollow articles which are prepared by the rotomolding process. Examples of polyolefins suitable for such use with the stabilizer composition according to the invention include at least the following:
    1. (A) Polymers of monoolefins and diolefins, for example polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, polyisoprene or polybutadiene, as well as polymers of cycloolefins, for instance of cyclopentene or norbornene, polyethylene (which optionally can be crosslinked), for example high density polyethylene (HDPE), high density and high molecular weight polyethylene (HDPE-HMW), high density and ultrahigh molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), (VLDPE) and (ULDPE);
    2. (B) Polyolefins, i.e. the polymers of monoolefins exemplified in (A), preferably polyethylene and polypropylene, can be prepared by different, and especially by the following, methods:
      1. i) radical polymerisation (normally under high pressure and at elevated temperature); or
      2. ii) catalytic polymerisation using a catalyst that normally contains one or more than one metal of groups IVb, Vb, VIb or VIII of the Periodic Table. These metals usually have one or more than one ligand, typically oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and/or aryls that may be either p- or s-coordinated. These metal complexes may be in the free form or fixed on substrates, typically on activated magnesium chloride, titanium(III) chloride, alumina or silicon oxide. These catalysts may be soluble or insoluble in the polymerisation medium. The catalysts can be used by themselves in the polymerisation or further activators may be used, typically metal alkyls, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkyloxanes, said metals being elements of groups Ia, IIa and/or IIIa of the Periodic Table. The activators may be modified conveniently with further ester, ether, amine or silyl ether groups. These catalyst systems are usually termed Phillips, Standard Oil Indiana, Ziegler (-Natta), TNZ (DuPont), metallocene or single site catalysts (SSC).
    3. (C) Mixtures of the polymers mentioned under (A), for example mixtures of polypropylene with polyisobutylene, polypropylene with polyethylene (for example PP/HDPE, PP/LDPE) and mixtures of different types of polyethylene (for example LDPE/HDPE).
    4. (D) Copolymers of monoolefins and diolefins with each other or with other vinyl monomers, for example ethylene/propylene copolymers, linear low density polyethylene (LLDPE) and mixtures thereof with low density polyethylene (LDPE), propylene/but-1-ene copolymers, propylene/isobutylene copolymers, ethylene/but-1-ene copolymers, ethylene/hexene copolymers, ethylene/methylpentene copolymers, ethylene/hepten copolymers, ethylene/octene copolymers, propylene/butadiene copolymers, isobutylene/isoprene copolymers, ethylene/alkyl acrylate copolymers, ethylene/alkyl methacrylate copolymers, ethylene/vinyl acetate copolymers and their copolymers with carbon monoxide or ethylene/acrylic acid copqlymers and their salts (ionomers) as well as terpolymers of ethylene with propylene and a diene such as hexadiene, dicyclopentadiene or ethylidene-norbornene; and mixtures of such copolymers with one another and with polymers mentioned in (A) above, for example polypropylene/ethylene-propylene copolymers, LDPE/ethylene-vinyl acetate copolymers (EVA), LDPE/ethylene-acrylic acid copolymers (EAA), LLDPE/EVA, LLDPE/EAA and alternating or random polyalkylene/carbon monoxide copolymers and mixtures thereof with other polymers, for example polyamides.


    [0055] The stabilized polymer compositions according to the invention may further include one or more co-stabilizers and/or additives that include, but are not limited to: hindered amine light stabilizers, hindered hydroxyl benzoates, nickel phenolates, ultraviolet light stabilizers, and combinations thereof in an amount effective to stabilize the polymer composition against the degradative effects of visible and/or ultraviolet light radiation.

    [0056] Suitable hindered amine light stabilizers for use with the processes and stabilized polymer compositions according to the invention include, for example, compounds having a molecular fragment according to Formula (VI):

    wherein R31 is chosen from: hydrogen; OH; C1-C20 hydrocarbyl; -CH2CN; C1-C12 acyl; and C1-C18 alkoxy; R38 is chosen from: hydrogen; and C1-C8 hydrocarbyl; and each of R29, R30, R32, and R33 is independently chosen from C1-C20 hydrocarbyl, or R29 and R30 and/or R32 and R33 taken together with the carbon to which they are attached form a C5-C10 cycloalkyl;
    or Formula (VIa)

    wherein

    m is an integer from 1 to 2;

    R39 is chosen from: hydrogen; OH; C1-C20 hydrocarbyl; -CH2CN; C1-C12 acyl; and C1-C18 alkoxy; and

    each of G1-G4 is independently chosen from C1-C20 hydrocarbyl.



    [0057] Hindered amine light stabilizers particularly suitable for use with the present invention include, but are not limited to, bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate; bis(2,2,6,6-tetramethylpiperidin-4-yl)succinate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)sebacate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl) n-butyl 3,5-di-tert-butyl-4-hydroxybenzylmalonate; a condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid; 2,2,6,6-tetramethylpiperidin-4-yl stearate; 2,2,6,6-tetramethylpiperidin-4-yl dodecanate; 1,2,2,6,6-pentamethylpiperidin-4-yl stearate; 1,2,2,6,6-pentamethylpiperidin-4-yl dodecanate; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; 4-benzoyl-2,2,6,6-tetramethylpiperidine; 4-stearyloxy-2,2,6,6-tetramethylpiperidine; bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinate; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine; a condensate of 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane; a condensate of 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane; 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; a condensate of 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylpiperidine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane; oxo-piperanzinyl-triazines; a reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane and epichlorohydrin;
    N-alkoxy hindered amine light stabilizers including, but not limited to, tetrakis(2,2,6,6-tetramethyl-4-piperidyl) butane-1,2,3,4-tetracarboxylate (MARK® LA-57;); 1,2,3,4-butanetetracarboxylic acid, tetrakis(1,2,2,6,6-pentamethyl-4-piperidinyl)ester (MARK® LA-52); 1,2,3,4-butanetetracarboxylic acid, 1,2,2,6,6-pentamethyl-4-piperdinyl tridecyl ester (MARK® LA-62); 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl tridecyl ester (MARK® LA-67); 1,2,3,4-butanetetracarboxylic acid, polymer with 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol,1,2,2,6,6-pentamethyl-4-piperdinyl ester (MARK® LA-63); 1,2,3,4-butanetetracarboxylic acid, polymer with 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol, 2,2,6,6-tetramethyl-4-piperdinyl ester (MARK® LA-68); bis(1-undecanoxy-2,2,6,6-tetramethylpiperidin-4-yl)carbonate (MARK® LA-81; aka STAB® LA-81 available from Adeka Palmarole, Saint-Louis, France); TINUVIN® 123; TINUVIN® NOR 371; TINUVIN ® XT-850/XT-855; FLAMESTAB® NOR 116; and those disclosed in EP 0 889 085;
    hydroxyl-substituted N-alkoxy HALS including, but not limited to, those disclosed in U.S. Patent No. 6,271,377 such as 1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethyl-4-piperdinol; 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine; 1-(4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octadecanoyloxy-2-methylpropane; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperdinol; a reaction product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperdinol and dimethylsuccinate;
    any of the tetramethylpiperidyl groups disclosed in WO 2007/104689 including, but not limited to, 2,2,4,4-tetramethyl-7-oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one (HOSTAVIN® N20); the ester of 2,2,6,6-tetramethyl-4-piperidinol with higher fatty acids (CYASORB® 3853); 3-dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione (SANDUVOR® 3055); and their wax reaction products such as HALS NOW (LS X-N-O-W1);
    piperizinone compounds and derivatives thereof disclosed in U.S. Patent Nos. 6,843,939; 7,109,259; 4,240,961; 4,480,092; 4,629,752; 4,639,479; 5,013,836; 5,310,771; and WO 88/08863 including, but not limited to, 1H-Pyrrole-2,5-dione, 1-octadecyl-, polymer with (1-methylethenyl)benzene and 1-(2,2,6,6-tetramethyl-4-piperidinyl)-1H-pyrrole-2,5-dione; piperazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris[3,3,5,5-tetramethyl-; piperazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris[3,3,4,5,5-pentamethyl-; the reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane and epichlorohydrin; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; the condensate of 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylpiperidine; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine; the condensate of 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane; the condensate of 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane; 2-[(2-hydroxyethyl)amino]-4,6-bis[N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino-1,3,5-triazine; propanedioic acid, [(4-methoxyphenyl)-methylene]-bis-(1,2,2,6,6-pentamethyl-4-piperidinyl) ester; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 1-[2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4-piperidinyl ester; N-(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-N'-dodecyloxalamide; tris(2,2,6,6-tetramethylpiperidin-4-yl)nitrilotriacetate; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl): 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(2,2,6,6-tetramethyl-4-piperidinyl); the condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine; 1,2,3,4-butanetetracarboxylic acid, 1,2,2,6,6-pentamethyl-4-piperidinyl tridecyl ester; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl tridecyl ester; tetrakis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; mixture of 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosane-20-propanoic acid-dodecylester and 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosane-20-propanoic acid-tetradecylester; 1H,4H,3H,8H-2,3a,4a,6,7a,8a-hexaazacyclopenta[def]fluorene-4,8-dione, hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-; polymethyl[propyl-3-oxy(2',2',6',6'-tetramethyl-4,4'-piperidinyl)]siloxane; polymethyl[propyl-3-oxy(1',2',2',6',6'-pentamethyl-4,4'-piperidinyl)]siloxane; copolymer of methylmethacrylate with ethyl acrylate and 2,2,6,6-tetramethylpiperidin-4-yl acrylate; copolymer of mixed C20 to C24 alpha-olefins and (2,2,6,6-tetramethylpiperidin-4-yl)succinimide; 1,2,3,4-butanetetracarboxylic acid, polymer with β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol, 1,2,2,6,6-pentamethyl-4-piperidinyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol, 2,2,6,6-tetramethyl-4-piperidinyl ester copolymer; 1,3-benzenedicarboxamide, N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl; 1,1'-(1,10-dioxo-1,10-decanediyl)-bis(hexahydro-2,2,4,4,6-pentamethylpyrimidine; ethane diamide, N-(1-acetyl-2,2,6,6-tetramethylpiperidinyl)-N'-dodecyl; formamide, N,N'-1,6-hexanediylbis[N-(2,2,6,6-tetramethyl-4-piperidinyl); D-glucitol, 1,3:2,4-bis-O-(2,2,6,6-tetramethyl-4-piperidinylidene)-; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxo-dispiro[5.1.11.2]heneicosane; propanamide, 2-methyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)-2-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]-; 7-oxa-3,20-diazadispiro[5.1.11.2]heneicosane-20-propanoic acid, 2,2,4,4-tetramethyl-21-oxo-, dodecyl ester; N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-aminopropionic acid dodecyl ester; N-(2,2,6,6-tetramethylpiperidin-4-yl)-N'-aminooxalamide; propanamide, N-(2,2,6,6-tetramethyl-4-piperidinyl)-3-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]-; mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; bis(2,2,6,6-tetramethylpiperidin-4-yl)succinate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl) n-butyl 3,5-di-tert-butyl-4-hydroxybenzylmalonate; tris(2,2,6,6-tetramethylpiperidin-4-yl)nitrilotriacetate; 1,1'-(1,2-ethanediyl)bis(3,3,5,5-tetramethylpiperazinone); 4-benzoyl-2,2,6,6-tetramethylpiperidine; 4-stearyloxy-2,2,6,6-tetramethylpiperidine; bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dione; bis(l-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinate; 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(2,2,6,6-tetramethyl-4-piperidinyl) and 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl); N1-(β-hydroxyethyl)3,3-pentamethylene-5,5-dimethylpiperazin-2-one; N1-tert-octyl-3,3,5,5-tetramethyl-diazepin-2-one; N1-tert-octyl-3,3-pentamethylene-5,5-hexamethylene-diazepin-2-one; N1-tert-octyl-3,3-pentamethylene-5,5-dimethylpiperazin-2-one; trans-1,2-cyclohexane-bis-(N1-5,5-dimethyl-3,3-pentamethylene-2-piperazinone; trans-1,2-cyclohexane-bis-(N1-3,3,5,5-dispiropentamethylene-2-piperazinone); N1-isopropyl-1,4-diazadispiro-(3,3,5,5)pentamethylene-2-piperazinone; N1-isopropyl-1,4-diazadispiro-3,3-pentamethylene-5,5-tetramethylene-2-piperazinone; N1-isopropyl-5,5-dimethyl-3,3-pentamethylene-2-piperazinone; trans-1,2-cyclohexane-bis-N1-(dimethyl-3,3-pentamethylene-2-piperazinone); N1-octyl-5,5-dimethyl-3,3-pentamethylene-1,4-diazepin-2-one; and N1-octyl-1,4-diazadispiro-(3,3,5,5)pentamethylene-1,5-diazepin-2-one. Other sterically hindered amines suitable for use with the invention include, for example, any of those disclosed in EP 1 308 084.

    [0058] The hindered amine component can be present in an amount from 0.01 to 10 % by weight based on the total weight of the polymer material to be stabilized. Preferably, the amount of hindered amine is available from 0.05 to 5 %, and more preferably from 0.1 to 3 % by weight based on the total weight of the polymer material to be stabilized.

    [0059] Other light stabilizers suitable for use with the present invention include one or more of the following:

    2-(2'-Hydroxyphenyl)benzotriazoles, for example 2-(2'-hydroxy-5'-methylphenyl)-benzotriazole; 2-(3',5'-di-tert-butyl-2'-hydroxyphenyl)benzotriazole; 2-(5'-tert-butyl-2'-hydroxyphenyl)benzotriazole; 2-(2'-hydroxy-5'-(1,1,3,3-tetramethylbutyl)phenyl)benzotriazole; 2-(3',5'-di-tert-butyl-2'-hydroxyphenyl)-5-chloro-benzotriazole; 2-(3-tert-butyl-2'-hydroxy-5'-methylphenyl)-5-chloro-benzotriazole; 2-(3'-sec-butyl-5'-tert-butyl-2'-hydroxyphenyl)benzotriazole; 2-(2'-hydroxy-4'-octyloxyphenyl)benzotriazole; 2-(3',5'-di-tert-amyl-2'-hydroxyphenyl)benzotriazole; 2-(3',5'-bis-(α,α-dimethylbenzyl)-2'-hydroxyphenyl)benzotriazole; 2-(3'-tert-butyl-2-hydroxy-5'-(2-octyloxycarbonylethyl)phenyl)-5-chloro-benzotriazole; 2-(3'-tert-butyl-5'-[2-(2-ethylhexyloxy)-carbonylethyl]-2'-hydroxyphenyl)-5-chloro-benzotriazole; 2-(3'-tert-butyl-2'-hydroxy-5'-(2-methoxycarbonylethyl)phenyl)-5-chloro-benzotriazole; 2-(3'-tert-butyl-2'-hydroxy-5'-(2-methoxycarbonylethyl)phenyl)benzotriazole; 2-(3'-tert-butyl-2'-hydroxy-5'-(2-octyloxycarbonylethyl)phenyl)benzotriazole; 2-(3'-tert-butyl-5'-[2-(2-ethylhexyloxy)carbonyl]-2'-hydroxyphenyl)benzotriazole; 2-(3'-dodecyl-2'-hydroxy-5'-methylphenyl)benzotriazole; 2-(3'-tert-butyl-2'-hydroxy-5'-(2-isooctyloxycarbonylethyl)phenylbenzotriazole; 2,2'-methylene-bis[4-(1,1,3,3-tetramethylbutyl)-6-benzotriazole-2-ylphenol]; the transesterification product of 2-[3'-tert-bulyl-5'-(2-methoxycarbonylethyl)-2'-hydroxyphenyl]-2H-benzotriazole with polyethylene glycol 300; [R-CH2CH2-COO-CH2CH2]2 where R=3'-tert-butyl-4'-hydroxy-5'-2H-benzotriazol-2-ylphenyl; 2-[2'-hydroxy-3'-(α,α-dimethylbenzyl)-5'-(1,1,3,3-tetramethylbutyl)-phenyl]benzotriazole; 2-[2'-hydroxy-3'-(1,1,3,3-tetramethylbutyl)-5'-(α,α-dimethylbenzyl)-phenyl]benzotriazole;

    2-Hydroxybenzophenones, for example the 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyloxy, 4-dodecyloxy, 4-benzyloxy, 4,2',4'-trihydroxy and 2'-hydroxy-4,4'-dimethoxy derivatives;

    Esters of substituted and unsubstituted benzoic acids, as for example 4-tertbutyl-phenyl salicylate, phenyl salicylate, octylphenyl salicylate, dibenzoyl resorcinol, bis(4-tert-butylbenzoyl)resorcinol, benzoyl resorcinol, 2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate, hexadecyl 3,5-di-tert-butyl-4-hydroxybenzoate, octadecyl 3,5-di-tert-butyl-4-hydroxybenzoate, 2-methyl-4,6-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate;

    Nickel compounds, for example nickel complexes of 2,2-thio-bis-[4-(1,1,3,3-tetramethylbutyl)phenol], such as the 1:1 or 1:2 complex, with or without additional ligands such as n-butylamine, triethanolamine or N-cyclohexyldiethanolamine, nickel dibutyldithiocarbamate, nickel salts of the monoalkyl esters, e.g. the methyl or ethyl ester, of 4-hydroxy-3,5-di-tert-butylbenzylphosphonic acid, nickel complexes of ketoximes, e.g. of 2-hydroxy-4-methylphenyl undecylketoxime, nickel complexes of 1-phenyl-4-lauroyl-5-hydroxypyrazole, with or without additional ligands; and

    2-(2'-hydroxyphenyl)-1,3,5-triazine compounds according to Formula (VII):

    wherein each of R34 and R35 is independently chosen from C6-C10 aryl optionally substituted, C1-C10 hydrocarbyl-substituted amino, C1-C10 acyl and C1-C10 alkoxyl; and wherein R36 is a substituent that is the same or different at from 0 to 4 positions of the phenoxy portion of Formula VII and is independently chosen from hydroxyl, C1-C12 hydrocarbyl, C1-C12 alkoxyl, C1-C12 alkoxyester, and C1-C12 acyl. Such 2-(2-Hydroxyphenyl)-1,3,5-triazines include, but are not limited to, 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-octyloxyphenyl)-s-triazine (CYASORB® 1164 available from Cytec Industries Inc.); 4,6-bis-(2,4-dimethylphenyl)-2-(2,4-- dihydroxyphenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(4-chlorophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(4-chlorophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(4-bromophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-acetoxyethoxy)phenyl]-6-(4-chlorophenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethylideneoxy]phenyl]-s-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-s-triazine; 2-phenyl-4-[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)phenyl]-6-[2-hydroxy-4-(3-sec-amyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(- 3-benzyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4-bis(2-hydroxy-4-n-butyloxyphenyl)-6-(2,4-di-n-butyloxyphenyl)-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-nonyloxy-2-hydroxypropylox-y)-5-α-cumylphenyl]-s-triazine; methylenebis-{2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-butyloxy-2-hydroxypropoxy)phenyl]-s-triazine}; methylene bridged dimer mixture bridged in the 3:5', 5:5' and 3:3' positions in a 5:4:1 ratio; 2,4,6-tris(2-hydroxy-4-isooctyloxycarbonyliso-propylideneoxy-phenyl)-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-cumylphenyl)-s-triazine; 2-(2,4,6-trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4,6-tris[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)-phenyl]-s-triazine; mixture of 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy)phenyl)-s-triazine and 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy)phenyl)-s-triazine (TINUVIN® 400 available from BASF Corp.); 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4(3-(2-ethylhexyloxy)-2-hydroxypropoxy)-phenyl)-s-triazine; 4,6-diphenyl-2-(4-hexyloxy-2-hydroxyphenyl)-s-triazine; 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethylhexanoyloxy)ethoxy]phenol (ADK STAB® LA-46 available from Adeka Palmarole, Saint-Louis, France); 2,4,6-tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-triazine; propanoic acid, 2,2',2"-[1,3,5-triazine-2,4,6-triyltris[(3-hydroxy-4,1-phenylene)oxy]]tris-1,1',1"-trioctyl ester (TINUVIN® 477 available from BASF Corp.); propanoic acid, 2-[4-[4,6-bis([1,1'-biphenyl]-4-yl)-1,3,5-triazin-2yl]-3-hydroxyphenoxyl]-isooctyl ester (TINUVIN® 479 available from BASF Corp.); and combinations thereof.



    [0060] In certain embodiments, the stabilized polymer compositions according to the invention include a blend of at least one hindered amine light stabilizer and at least one ultraviolet light absorber.

    [0061] Further embodiments of the stabilized polymer compositions according to the invention include at least one compound chosen from:

    a hydroxylamine compound according to Formula VIII:

    wherein

    T1 is chosen from C1-C36 hydrocarbyl, C5-C12 cycloalkyl, and C7-C9 aralkyl, optionally substituted; and

    T2 is chosen from hydrogen or T1; and

    a tertiary amine oxide compound according to Formula IX:

    wherein

    W1 and W2 are each independently chosen from a C6-C36 hydrocarbyl chosen from a straight or branched chain C6-C36 alkyl, C6-C12 aryl, C7-C36 aralkyl, C7-C36 alkaryl, C5-C36 cycloalkyl, C6-C36 alkcycloalkyl; and C6-C36 cycloalkylalkyl;

    W3 is chosen from a C1-C36 hydrocarbyl chosen from a straight or branched chain C1-C36 alkyl, C6-C12 aryl, C7-C36 aralkyl, C7-C36 alkaryl, C5-C36 cycloaklyl, C6-C36 alkcycloalkyl; and C6-C36 cycloalkylalkyl; with the proviso that at least one of W1, W2 and W3 contains a β carbon-hydrogen bond; and wherein said alkyl, aralkyl, alkaryl, cycloalkyl, alkcycloalkyl and cycloalkylalkyl groups may be interuppted by one to sixteen -O-, -O-, -SO-, -SO2 -, -COO-, -OCO-, -CO-, -NW4-, -CONW4- and -NW4 CO- groups, or wherein said alkyl, aralkyl, alkaryl, cycloalkyl, alkcycloalkyl and cycloalkylallyl groups may be substituted by one to sixteen groups selected from -OW4, -SW4, -COOW4, -OCOW4, -COW4, -N(W4)2, -CON(W4)2, -NW4COW4 and 5- and 6-membered rings containing the -C(CH3)(CH2Rx)NL(CH2Rx)(CH3)C- group or wherein said alkyl, aralkyl, alkaryl, cycloalkyl, alkcycloalkyl and cycloalkylalkyl groups are both interuppted and substituted by the groups mentioned above; and

    wherein

    W4 is chosen from hydrogen or C1-C8 alkyl;

    Rx is chosen from hydrogen or methyl; and

    L is chosen from a C1-C30 alkyl, a -C(O)R moiety wherein R is a C1-C30 straight or branched chain alkyl group, or a --OR moiety wherein R is a C1-C30 straight or branched chain alkyl group; and wherein said aryl groups may be substituted by one to three halogen, C1-C8 alkyl, C1-C8 alkoxy or combinations thereof.



    [0062] In particular embodiments, preference is given to N,N-dihydrocarbylhydroxylamine compounds according to Formula VIII wherein T1 and T2 are independently chosen from benzyl, ethyl, octyl, lauryl, dodecyl, tetradecyl, hexadecyl, heptadecyl and octadecyl; or wherein T1 and T are each the alkyl mixture found in hydrogenated tallow amine.

    [0063] In certain embodiments, hydroxylamine compounds according to Formula VIII are chosen from: N,N-dibenzylhydroxylamine; N,N-diethylhydroxylamine; N,N-dioctylhydroxylamine; N,N-dilaurylhydroxylamine; N,N-didodecylhydroxylamine; N,N-ditetradecylhydroxylaamine; N,N-dihexadecylhydroxylamine; N,N-dioctadecylhydroxylamine; N-hexadecyl-N-tetradecylhydroxylamine; N-hexadecyl-N-heptadecylhydroxylamine; N-hexadecyl-N-octadecylhydroxylamine; N-heptadecyl-N-octadecylhydroxylamine; N,N-di(hydrogenated tallow)hydroxylamine; and N,N-di(alkyl)hydroxylamine produced by the direct oxidation of N,N-di(hydrogenated tallow)amine.

    [0064] In certain embodiments, preference is given to those structures of Formula IX where W1 and W2 are independently benzyl or substituted benzyl. It is also possible for each of W1, W2, and W3 to be the same residue. In other embodiments, W1 and W2 can be alkyl groups of 8 to 26 carbon atoms, more preferably alkyl groups of 10 to 26 carbon atoms. W3 can be an alkyl group of 1 to 22 carbon atoms, more preferably methyl or substituted methyl. Other preferred amine oxides include those wherein W1, W2, and W3 are the same alkyl groups of 6 to 36 carbon atoms. Preferably, all of the aforementioned residues for W1, W2, and W3 are saturated hydrocarbon residues or saturated hydrocarbon residues containing at least one of the aforementioned -O-, -O-, -SO-, -CO2-, -CO-, or -CON- moieties. Those skilled in the art will be able to envision other useful residues for each of W1, W2, and W3 without detracting from the present invention.

    [0065] The saturated amine oxides may also includes poly(amine oxides). By poly(amine oxide) is meant tertiary amine oxides containing at least two tertiary amine oxides per molecule. Illustrative poly(amine oxides), also called "poly(tertiary amine oxides)", include, but are not limited to, the tertiary amine oxide analogues of aliphatic and alicyclic diamines such as, for example, 1,4-diaminobutane; 1,6-diaminohexane; 1,10-diaminodecane; and 1,4-diaminocyclohexane, and aromatic based diamines such as, for example, diamino anthraquinones and diaminoanisoles.

    [0066] Suitable amine oxides for use with the invention also include tertiary amine oxides derived from oligomers and polymers of the aforementioned diamines. Useful amine oxides also include amine oxides attached to polymers, for example, polyolefins, polyacrylates, polyesters, polyamides, polystyrenes, and the like. When the amine oxide is attached to a polymer, the average number of amine oxides per polymer can vary widely as not all polymer chains need to contain an amine oxide. All of the aforementioned amine oxides may optionally contain at least one -O-, -O-, -SO-, -CO2-, -CO-, or -CONW4-moiety. In a preferred embodiment, each tertiary amine oxide of the polymeric tertiary amine oxide contains a C1 residue.

    [0067] The groups W1, W2 and W3 of Formula IX may be attached to a molecule containing a hindered amine. Hindered amines are known in the art and the amine oxide of the present invention may be attached to the hindered amine in any manner and structural position of the hindered amine. Useful hindered amines when part of an amine oxide compound include those of the general Formulas X and XI:



    wherein L and Rx are defined as described above.

    [0068] Also included are amine oxides containing more than one hindered amine and more than one saturated amine oxide per molecule. The hindered amine may be attached to a poly(tertiary amine oxide) or attached to a polymeric substrate, as discussed above.

    [0069] The hydroxyl amine derivatives and/or amine oxide derivatives can be used in amounts, in total, of about 0.0005% to about 5%, in particular from about 0.001% to about 2%, typically from about 0.01% to about 2% by weight, based on the weight of the polyolefin hollow article to be stabilized.

    [0070] In other embodiments, the stabilized polymer compositions include further optional additives that can include at least one compound chosen from co-additives; nucleating agents; fillers; reinforcing agents; and combinations thereof.

    [0071] Examples of such additives include, but are not limited to:

    Basic co-additives, for example, melamine, polyvinylpyrrolidone, dicyandiamide, triallyl cyanurate, urea derivatives, hydrazine derivatives, amines, polyamides, polyurethanes, alkali metal salts and alkaline earth metal salts of higher fatty acids for example calcium stearate, zinc stearate, magnesium behenate, magnesium stearate, sodium ricinoleate and potassium palmitate, antimony pyrocatecholate or zinc pyrocatecholate;

    Nucleating agents, for example, inorganic substances such as talcum, metal oxides such as titanium dioxide or magnesium oxide, phosphates, carbonates or sulfates of, preferably, alkaline earth metals; organic compounds such as mono- or polycarboxylic acids and the salts thereof, e.g. 4-tert-butylbenzoic acid, adipic acid, diphenylacetic acid, sodium succinate or sodium benzoate; polymeric compounds such as ionic copolymers (ionomers);

    Fillers and reinforcing agents, for example, calcium carbonate, silicates, glass fibres, glass bulbs, asbestos, talc, kaolin, mica, barium sulfate, metal oxides and hydroxides (e.g., aluminium hydroxide or magnesium hydroxide, carbon black, graphite, wood flour and flours or fibers of other natural products, synthetic fibers; impact modifiers



    [0072] Benzofuranones and indolinones, for example those disclosed in U.S. Pat. Nos. 4,325,863; 4,338,244; 5,175,312; 5,216,052; 5,252,643; 5,369,159; 5,488,117; 5,356,966; 5,367,008; 5,428,162; 5,428,177; 5,516,920; DE-A-4316611; DE-A-4316622; DE-A-4316876; EP-A-0589839 or EP-A-0591102 or 3-[4-(2-acetoxyethoxy)phenyl]-5,7-di-tert-butyl-benzofuran-2-one, 5,7-di-tert-butyl-3-[4-(2-stearoyloxyethoxy)phenyl]benzofuran-2-one, 3,3'-bis[5,7-di-tert-butyl-3-(4-[2-hydroxyethoxy]phenyl)benzofuran-2-one], 5,7-di-tert-butyl-3-(4-ethoxyphenyl)benzofuran-2-one, 3-(4-acetoxy-3,5-dimethylphenyl)-5,7-di-tert-butyl-benzofuran-2-one, 3-(3,5-dimethyl-4-pivaloyloxyphenyl)-5,7-di-tert-butyl-benzofuran-2-one, 3-(3,4-dimethylphenyl)-5,7-di-tert-butyl-benzofuran-2-one, 3-(2,3-dimethylphenyl)-5,7-di-tert-butyl-benzofuran-2-one;
    Metal deactivators, for example N,N'-diphenyloxamide, N-salicylal-N'-salicyloyl hydrazine, N,N'-bis(salicyloyl)hydrazine, N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl) hydrazine, 3-salicyloylamino-1,2,4-triazole, bis(benzylidene)oxalyl dihydrazide, oxanilide, isophthaloyl dihydrazide, sebacoyl bisphenylhydrazide, N,N'-diacetyladipoyl dihydrazide, N,N'-bis(salicyloyl)oxalyl dihydrazide, N,N'-bis(salicyloyl)thiopropionyl dihydrazide;
    Nitrones, for example, N-benzyl-alpha-phenyl-nitrone, N-ethyl-alpha-methyl-nitrone, N-octyl-alpha-heptyl-nitrone, N-lauryl-alpha-undecyl-nitrone, N-tetradecyl-alpha-tridcyl-nitrone, N-hexadecyl-alpha-pentadecyl-nitrone, N-octadecyl-alpha-heptadecyl-nitrone, N-hexadecyl-alpha-heptadecyl-nitrone, N-ocatadecyl-alpha-pentadecyl-nitrone, N-heptadecyl-alpha-heptadecyl-nitrone, N-octadecyl-alpha-hexadecyl-nitrone, nitrone derived from N,N-di(hydrogenated tallow)hydroxylamine;
    Thiosynergists, for example, dilauryl thiodipropionate or distearyl thiodipropionate; and
    Peroxide scavengers, for example esters of β-thiodipropionic acid, for example the lauryl, stearyl, myristyl or tridecyl esters, mercaptobenzimidazole or the zinc salt of 2-mercaptobenzimidazole, zinc dibutyldithiocarbamate, dioctadecyl disulfide, pentaerythritol tetrakis(β-dodecylmercapto)propionate.

    [0073] Other additives include, for example, plasticisers, lubricants, emulsifiers, pigments, rheology additives, catalysts, flow-control agents, optical brighteners, flameproofing agents, antistatic agents, clarifying agents and blowing agents.

    [0074] In certain embodiments, the stabilizer composition is present from 0.001 to 65.0 % by weight based on the total weight of the polymer composition to be stabilized and based on the number and type of stabilizing additives being added and/or the characteristics of the polymer composition to be stabilized. In some embodiments, the stabilizer composition is present from 0.01 to 50 % by weight of the total weight of the polymer composition, and preferably from 0.05 to 25 % by weight of the total, or from 0.1 to 10 % by weight of the total. Those of ordinary skill in the art will be able to readily determine the amount and type of stabilizing additive(s) that should be added based on preparations as known and/or described in the literature, or through no more than routine experimentation.

    [0075] The stabilized polymer compositions according to the invention can be readily made by any suitable method known to those of skill in the art. In certain embodiments, the components of the stabilized polymer compositions are mixed by at least one technique chosen from extruding, pelletizing, grinding, and molding. In other embodiments, mixing can be performed by at least one of melting, dissolution in a solvent, and dry mixing.

    [0076] The incorporation of components for the stabilizer composition and optional further additives into the polymer composition is carried out by any suitable method known to those of skill in the art, for example before or after molding or also by applying the dissolved or dispersed stabilizer mixture to the polyolefin, with or without subsequent evaporation of the solvent. The stabilizer components and optional further additives can also be added to the polymer compositions to be stabilized in the form of a masterbatch.

    [0077] Components of the stabilizer composition and optional further additives can also be added before or during the polymerization or before crosslinking. They can also be incorporated into the polymer composition to be stabilized in pure form (i.e., neat and directly to the resin) or encapsulated in waxes, oils or polymers. Various additives can also be preblended (i.e., mixed together) for simple addition to the polymer compositions to be stabilized. Components of the stabilizer composition and optional further additives can also be sprayed onto the polymer compositions to be stabilized. They are able to dilute other additives (for example the conventional additives indicated above) or their melts so that they can be sprayed also together with these additives onto the polymer compositions to be stabilized. In the case of spherically polymerized polymers it may, for example, be advantageous to apply components of the stabilizer composition optionally together with other additives, by spraying.

    [0078] It is also contemplated that the components of the stabilizer compositions and/or polymer compositions described herein may be contained in a kit. The kit may include single or multiple components of at least one stabilizer composition according to the invention, at least one polymer composition according to the invention, and at least one further optional additive, each packaged or formulated individually, or single or multiple components of at least one stabilizer composition according to the invention, at least one polymer composition according to the invention, and at least one further optional additive packaged or formulated in combination. Thus, one or more components of a stabilizer composition can be in first container, and the kit can optionally include one or more components of the stabilizer composition and/or polymer composition in a second or further container. The container or containers are placed within a package, and the package can optionally include administration or mixing instructions in the form of a label or website address on the package, or in the form of an insert included in the packaging of the kit. A kit can include additional components or other means for administering or mixing the components as well as solvents or other means for formulation.

    [0079] Disclosed herein are:
    1. 1. A process for reducing cycle time in a rotational molding process for producing a polymeric hollow article, the process comprising:
      subjecting a polymer composition and a polymer-stabilizing amount of a stabilizer composition to a rotational molding process, wherein the stabilizer composition comprises:
      1. i) at least one chroman-based compound according to Formula V

        wherein

        R21 is a substituent that can be the same or different at from 0 to 4 positions of the aromatic portion of Formula V and is independently chosen from:

        C1-C12 hydrocarbyl;

        NR'R", wherein each of R' and R" is independently chosen from H and C1-C12 hydrocarbyl; and

        OR27, wherein R27 is chosen from: H; C1-C12 hydrocarbyl; COR"'; and Si(R28)3, wherein R'" is chosen from H and C1-C20 hydrocarbyl; and wherein R28 is chosen from C1-C12 hydrocarbyl and alkoxy;

        R22 is chosen from: H; and C1-C12 hydrocarbyl;

        R23 is chosen from H; and C1-C20 hydrocarbyl; and

        each of R24-R25 is independently chosen from: H; C1-C12 hydrocarbyl; and OR"", wherein R"" is chosen from H and C1-C12 hydrocarbyl; and

        R26 is H, or a bond which together with R25 forms =O.

    2. 2. A process according to embodiment 1, wherein the cycle time is reduced by at least 4 to 50 %.
    3. 3. A process for producing a polymeric hollow article, the process comprising:
      1. a) filling a mold with a polymer composition and a polymer-stabilizing amount of a stabilizer composition, wherein the stabilizer composition comprises:
        at least one chroman-based compound according to Formula V

        wherein

        R21 is a substituent that can be the same or different at from 0 to 4 positions of the aromatic portion of Formula V and is independently chosen from:

        C1-C12 hydrocarbyl;

        NR'R", wherein each of R' and R" is independently chosen from H and C1-C12 hydrocarbyl; and

        OR27, wherein R27 is chosen from: H; C1-C12 hydrocarbyl; COR"'; and Si(R28)3, wherein R''' is chosen from H and C1-C20 hydrocarbyl; and wherein R28 is chosen from C1-C12 hydrocarbyl and alkoxy;

        R22 is chosen from: H; and C1-C12 hydrocarbyl;

        R23 is chosen from H; and C1-C20 hydrocarbyl; and

        each of R24-R25 is independently chosen from: H; C1-C12 hydrocarbyl; and OR"", wherein R"" is chosen from H and C1-C12 hydrocarbyl; and

        R26 is H, or a bond which together with R25 forms =O;

      2. b) rotating the mold around at least 1 axis while heating the mold in an oven, thereby fusing the composition and spreading it to the walls of the mold;
      3. c) cooling the mold; and
      4. d) opening the mold to remove the resulting product,
        thereby producing a polymeric hollow article.
    4. 4. A process according to embodiment 3, wherein the temperature of the oven ranges from 70° C up to 400° C.
    5. 5. A process according to any of the preceding embodiments, wherein the stabilizer composition further comprises at least one compound chosen from the group of organic phosphites or phosphonites.
    6. 6. A process according to embodiment 5, wherein the at least one organic phosphite or phosphonite is chosen from a compound according to Formulas 1-7:













      in which the indices are integral and

      n is 2, 3 or 4; p is 1 or 2; q is 2 or 3; r is 4 to 12; y is 1, 2 or 3; and z is 1 to 6;

      A1, if n is 2, is C2-C18 alkylene; C2-C12 alkylene interrupted by oxygen, sulfur or -NR4-; a radical of the formula

      or phenylene;

      A1, if n is 3, is a radical of the formula -CrH2r-1-;

      A1, if n is 4, is

      A2 is as defined for A1 if n is 2;

      B is a direct bond, -CH2-, -CHR4-, -CR1R4-, sulfur, C5-C7 cycloalkylidene, or cyclohexylidene which is substituted by from 1 to 4 C1-C4 alkyl radicals in position 3, 4 and/or 5;

      D1, if p is 1, is C1-C4 alkyl and, if p is 2, is -CH2OCH2-;

      D2, if p is 1, is C1-C4 alkyl;

      E, if y is 1, is C1-C18 alkyl, -OR1 or halogen;

      E, if y is 2, is -O-A2-O-,

      E, if y is 3, is a radical of the formula R4C(CH2O-)3 or N(CH2CH2O-)3;

      Q is the radical of an at least z-valent alcohol or phenol, this radical being attached via the oxygen atom to the phosphorus atom;

      R1, R2 and R3 independently of one another are C1-C18 alkyl which is unsubstituted or substituted by halogen, -COOR4, -CN or -CONR4R4; C2-C18 alkyl interrupted by oxygen, sulfur or -NR4-; C7-C9 phenylalkyl; C5-C12 cycloalkyl, phenyl or naphthyl; naphthyl or phenyl substituted by halogen, 1 to 3 alkyl radicals or alkoxy radicals having a total of 1 to 18 carbon atoms or by C7-C9 phenylalkyl; or a radical of the formula

      in which m is an integer from the range 3 to 6;

      R4 is hydrogen, C1-C8 alkyl, C5-C12 cycloalkyl or C7-C9 phenylalkyl,

      R5 and R6 independently of one another are hydrogen, C1-C8 alkyl or C5-C6 cycloalkyl,

      R7 and R8, if q is 2, independently of one another are C1-C4 alkyl or together are a 2,3-dehydropentamethylene radical; and

      R7 and R8, if q is 3, are methyl;

      R14 is hydrogen, C1-C9 alkyl or cyclohexyl,

      R15 is hydrogen or methyl and, if two or more radicals R14 and R15 are present, these radicals are identical or different,

      X and Y are each a direct bond or oxygen,

      Z is a direct bond, methylene, -C(R16)2- or sulfur, and

      R16 is C1-C8 alkyl;

      a trisarylphosphite according to Formula 8:

      wherein R17 is a substituent that is the same or different at from 0 to 5 positions of the aromatic portion of Formula 8 and is independently chosen from C1-C20 alkyl, C3-C20 cycloalkyl, C4-C20 alkyl cycloalkyl, C6-C10 aryl, and C7-C20 alkylaryl; and combinations thereof.
    7. 7. A process according to embodiment 6, wherein the organic phosphite or phosphonite is chosen from: triphenyl phosphite; diphenyl alkyl phosphites; phenyl dialkyl phosphites; trilauryl phosphite; trioctadecyl phosphite; distearyl pentaerythritol phosphite; tris(2,4-di-tert-butylphenyl) phosphite; tris(nonylphenyl) phosphite; a compound of formulae (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) and (L):





















      2-butyl-2-ethyl-1,3-propanediol 2,4,6-tri-t-butylphenol phosphite; bis-(2,6-di-t-butyl-4-methlphenyl) pentaerythritol diphosphite; 2-butyl-2-ethyl-1,3-propanediol 2,4-di-cumylphenol phosphite; 2-butyl-2-ethyl-1,3-propanediol 4-methyl-2,6-di-t-butylphenol phosphite; bis-(2,4,6-tri-t-butyl-phenyl) pentaerythritol diphosphite; and combinations thereof.
    8. 8. A process according to any one of embodiments 5-7, wherein the at least one organic phosphite or phosphonite is chosen from tris(2,4-di-tert-butylphenyl)phosphite (IRGAFOS® 168); Bis(2,4-dicumylphenyl)pentaerythritol diphosphite (DOVERPHOS® S9228); and tetrakis(2,4-di-tert-butylphenyl)4,4'-biphenylene-diphosphonite (IRGAFOS® P-EPQ).
    9. 9. A process according to any one of the preceding embodiments, wherein the stabilizer composition further comprises at least one hindered phenol compound.
    10. 10. A process according to embodiment 9, wherein the at least one hindered phenol compound comprises a molecular fragment according to one or more of Formula (IVa), (IVb), or (IVc):

      wherein

      R18 is chosen from hydrogen and a C1-4 hydrocarbyl;

      R19 and R20 are each individually chosen from hydrogen and a C1-C20 hydrocarbyl; and

      R37 is chosen from C1-C12 hydrocarbyl.

    11. 11. A process according to embodiment 10, wherein R18 and R37 are chosen from methyl and t-butyl.
    12. 12. A process according to any one of embodiments 9-11, wherein the at least one hindered phenol compound is chosen from: (1,3,5-Tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione; 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; 1,1,3-Tris(2'-methyl-4'-hydroxy-5'-t-butylphenyl)butane; Triethylene glycol bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionate]; 4,4'-Thiobis(2-t-butyl-5-methylphenol); 2,2'-Thiodiethylene bis[3-(3-t-butyl-4-hydroxyl-5-methylphenyl)propionate]; Octadecyl 3-(3'-t-butyl-4'-hydroxy-5'-methylphenyl)propionate; Tetrakismethylene (3-t-butyl-4-hydroxy-5-methylhydrocinnamate)methane; N,N'-Hexamethylene bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionamide]; Di(4-tertiarybutyl-3-hydroxy-2,6-dimethyl benzyl) thiodipropionate; and octadecyl 3,5-di-(tert)-butyl-4-hydroxyhydrocinnamate.
    13. 13. A process according to any of the preceding embodiments, wherein R21 is present in at least one instance as OR27.
    14. 14. A process according to embodiment 13, wherein R21 is present in at least three instances and is chosen from OR27 and methyl.
    15. 15. A process according to any of the preceding embodiments, wherein R23 is a C1-C18 hydrocarbyl.
    16. 16. A process according to any of the preceding embodiments, wherein the chroman-based compound according to Formula V is a tocopherol.
    17. 17. A process according to any of the preceding embodiments, wherein the chroman-based compound is vitamin E or its acetate according to Formula Va

      wherein R21 is chosen from OH; and -OC(O)CH3, respectively.
    18. 18. A process according to any of the preceding embodiments, wherein the chroman-based compound is a blend of compounds according to Formula V.
    19. 19. A process according to any of the preceding embodiments, wherein the chroman-based compound is present from 0.001 to 5.0 % by weight of the total weight of the stabilizer composition.
    20. 20. A process according to embodiment 19, wherein the chroman-based compound is present from 0.01 to 1.0 % by weight of the total weight of the stabilizer composition,
    21. 21. A process according to any of the preceding embodiments, wherein the polymer composition comprises a polyolefin chosen from: i) polymers of monoolefins and diolefins chosen from polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, polyisoprene, and polybutadiene; ii) polymers of cycloolefins chosen from cyclopentene, and norbornene; iii) polyethylene chosen from optionally crosslinked polyethylene, high density polyethylene (HDPE), high density and high molecular weight polyethylene (HDPE-HMW), high density and ultrahigh molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), very low density polyethylene (VLDPE), and ultralow density polyethylene (ULDPE); iv) copolymers thereof; and v) mixtures thereof.
    22. 22. A process according to any of the preceding embodiments, wherein the polymer composition further comprises a light stabilizer chosen from: hindered amine light stabilizers, hindered hydroxyl benzoates, nickel phenolates, ultraviolet light stabilizers, and combinations thereof in an amount effective to stabilize the polymer composition against the degradative effects of visible and/or ultraviolet light radiation.
    23. 23. A process according to embodiment 22, wherein the light stabilizer is a hindered amine light stabilizer compound comprising a molecular fragment according to Formula (VI):

      wherein

      R31 is chosen from: hydrogen; OH; C1-C20 hydrocarbyl; -CH2CN; C1-C12 acyl; and C1-C18 alkoxy;

      R38 is chosen from: hydrogen; and C1-C8 hydrocarbyl; and

      each of R29, R30, R32, and R33 is independently chosen from C1-C20 hydrocarbyl, or R29 and R30 and/or R32 and R33 taken together with the carbon to which they are attached form a C5-C10 cycloalkyl;

      or Formula (VIa)

      wherein

      m is an integer from 1 to 2;

      R39 is chosen from: hydrogen; OH; C1-C20 hydrocarbyl; -CH2CN; C1-C12 acyl; and C1-C18 alkoxy; and

      each of G1-G4 is independently chosen from C1-C20 hydrocarbyl.

    24. 24. A process according to embodiment 22 or embodiment 23, wherein the hindered amine light stabilizer is chosen from: bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate; bis(2,2)6,6-tetramethylpiperidin-4-yl)succinate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)sebacate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl) n-butyl 3,5-di-tert-butyl-4-hydroxybenzylmalonate; a condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid; 2,2,6,6-tetramethylpiperidin-4-yl stearate; 2,2,6,6-tetramethylpiperidin-4-yl dodecanate; 1,2,2,6,6-pentamethylpiperidin-4-yl stearate; 1,2,2,6,6-pentamethylpiperidin-4-yl dodecanate; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; 4-benzoyl-2,2,6,6-tetramethylpiperidine; 4-stearyloxy-2,2,6,6-tetramethylpiperidine; bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinate; a condensate of N,'N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine; a condensate of 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane; a condensate of 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane; 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; a condensate of 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylpiperidine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane; oxo-piperanzinyl-triazines; a reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane and epichlorohydrin; tetrakis(2,2,6,6-tetramethyl-4-piperidyl) butane-1,2,3,4-tetracarboxylate; 1,2,3,4-butanetetracarboxylic acid, tetrakis(1,2,2,6,6-pentamethyl-4-piperidinyl)ester; 1,2,3,4-butanetetracarboxylic acid, 1,2,2,6,6-pentamethyl-4-piperdinyl tridecyl ester; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl tridecyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol,1,2,2,6,6-pentamethyl-4-piperdinyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol,2,2,6,6-tetramethyl-4-piperdinyl ester; bis(1-undecanoxy-2,2,6,6-tetramethylpiperidin-4-yl)carbonate; 1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethyl-4-piperdinol; 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine; 1-(4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octadecanoyloxy-2-methylpropane; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperdinol; a reaction product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperdinol and dimethylsuccinate; 2,2,4,4-tetramethyl-7-oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one; the ester of 2,2,6,6-tetramethyl-4-piperidinol with higher fatty acids; 3-dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione; 1H-Pyrrole-2,5-dione, 1-octadecyl-, polymer with (1-methylethenyl)benzene and 1-(2,2,6,6-tetramethyl-4-piperidinyl)-1H-pyrrole-2,5-dione; piperazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris[3,3,5,5-tetramethyl-; piperazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris[3,3,4,3,5-pentamethyl-; the reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane and epichlorohydrin; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; the condensate of 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylpiperidine; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine; the condensate of 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane; the condensate of 2-chbro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane; 2-[(2-hydroxyethyl)amino]-4,6-bis[N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino-1,3,5-triazine; propanedioic acid, [(4-methoxyphenyl)-methylene]-bis-(1,2,2,6,6-pentamethyl-4-piperidinyl) ester; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 1-[2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4-piperidinyl ester; N-(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-N'-dodecyloxalamide; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl): 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylie acid, bis(2,2,6,6-tetramethyl-4-piperidinyl); the condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine; 1,2,3,4-butanetetracarboxylic acid, 1,2,2,6,6-pentamethyl-4-piperidinyl tridecyl ester; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl tridecyl ester; tetrakis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; mixture of 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosane-20-propanoic acid-dodecylester and 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosane-20-propanoic acid-tetradecylester; 1H,4H,5H,8H-2,3a,4a,6,7a,8a-hexaazacyclopenta[def]fluorene-4,8-dione, hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-; polymethyl[propyl-3-oxy(2',2',6',6'-tetramethyl-4,4'-piperidinyl)]siloxane; potymethyl[propyl-3-oxy(1',2',2',6',6'-pentamethyl-4,4'-piperidinyl)]siloxane; copolymer of methylmethacrylate with ethyl acrylate and 2,2,6,6-tetramethylpiperidin-4-yl acrylate; copolymer of mixed C20 to C24 alpha-olefins and (2,2,6,6-tetramethylpiperidin-4-yl)succinimide; 1,2,3,4-butanetetracarboxylic acid, polymer with β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol, 1,2,2,6,6-pentamethyl-4-piperidinyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol, 2,2,6,6-tetramethyl-4-piperidinyl ester copolymer; 1,3-benzenedicarboxamide, N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl; 1,1'-(1,10-dioxo-1,10-decanediyl)-bis(hexahydro-2,2,4,4,6-pentamethylpyrimidine; ethane diamide, N-(1-acetyl-2,2,6,6-tetramethylpiperidinyl)-N'-dodecyl; formamide, N,N'-1,6-hexanediylbis[N-(2,2,6,6-tetramethyl-4-piperidinyl); D-glucitol, 1,3:2,4-bis-O-(2,2,6,6-tetramethyl-4-piperidinylidene)-; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxo-dispiro[5.1.11.2]heneicosane; propanamide, 2-methyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)-2-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]-;7-oxa-3,20-diazadispiro[5.1.11.2]heneicosane-20-propanoic acid, 2,2,4,4-tetramethyl-21-oxo-, dodecyl ester; N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-aminopropionic acid dodecyl ester; N-(2,2,6,6-tetramethylpiperidin-4-yl)-N'-aminooxalamide; propanamide, N-(2,2,6,6-tetramethyl-4-piperidinyl)-3-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]-; mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; bis(2,2,6,6-tetramethylpiperidin-4-yl)succinate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl) n-butyl 3,5-di-tert-butyl-4-hydroxybenzylmalonate; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; 1,1'-(1,2-ethanediyl)bis(3,3,5,5-tetramethylpiperazinone); 4-benzoyl-2,2,6,6-tetramethylpiperidine; 4-stearyloxy-2,2,6,6-tetramethylpiperidine; bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinate; 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; a mixture of 4-hexadecyloxy- and 4-steatyloxy-2,2,6,6-tetramethylpiperidine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(2,2,6,6-tetramethyl-4-piperidinyl) and 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl); N1-(β-hydroxyethyl)3,3-pentamethylene-5,5-dimethylpiperazin-2-one; N1-tert-octyl-3,3,5,5-tetramethyl-diazepin-2-one; N1-tert-octyl-3,3-pentamethylene-5,5-hexamethylene-diazepin-2-one; N1-tert-octyl-3,3-pentamethylene-5,5-dimethylpiperazin-2-one; trans-1,2-cyclohexane-bis-(N1-5,5-dimethyl-3,3-pentamethylene-2-piperazinone; trans-1,2-cyclohexane-bis-(N1-3,3,5,5-dispiropentamethylene-2-piperazinone); N1-isopropyl-1,4-diazadispiro-(3,3,5,5)pentamethylene-2-piperazinone; N1-isopropyl-1,4-diazadispiro-3,3-pentamethylene-5,5-tetramethylene-2-piperazinone; N1-isopropyl-5,5-dimethyl-3,3-pentamethylene-2-piperazinone; trans-1,2-cyclohexane-bis-N1-(dimethyl-3,3-pentamethylene-2-piperazinone); N1-octyl-5,5-dimethyl-3,3-pentamethylene-1,4-diazepin-2-one; and N1-octyl-1,4-diazadispiro-(3,3,5,5)pentamethylene-1,5-diazepin-2-one.
    25. 25. A process according to embodiment 22, wherein the light stabilizer is an ultraviolet light absorber chosen from a 2-hydroxybenzophenone compound, a 2-(2'-hydroxyphenyl)benzotriazole compound, a 2-(2'-hydroxyphenyl)-1,3,5-triazine compound, and combinations thereof.
    26. 26. A process according to embodiment 25, wherein the ultraviolet light absorber is a 2-(2'-hydroxyphenyl)-1,3,5-triazine compound according to Formula (VII):

      wherein each of R34 and R35 is independently chosen from C6-C10 aryl optionally substituted, C1-C10 hydrocarbyl-substituted amino, C1-C10 acyl and C1-C10 alkoxyl; and wherein R36 is a substituent that is the same or different at from 0 to 4 positions of the phenoxy portion of Formula VII and is independently chosen from hydroxyl, C1-C12 hydrocarbyl, C1-C12 alkoxyl, C1-C12 alkoxyester, and C1-C12 acyl.
    27. 27. A process according to any one of embodiments 25-26, wherein the 2-(2'-hydroxyphenyl)-1,3,5-triazine compound is chosen from: 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-octyloxyphenyl)-s-triazine; 4,6-bis-(2,4-dimethylphenyl)-2-(2,4-- dihydroxyphenyl)-s-triazine;2,4-bis(2,4-dihydroxyphenyl)-6-(4-chlorophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(4-chlorophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(4-bromophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-acetoxyethoxy)phenyl]-6-(4-chlorophenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethylideneoxy]phenyl]-s-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-s-triazine; 2-phenyl-4-[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)phenyl]-6-[2-hydroxy-4-(3-sec-amyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(-3-benzyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4-bis(2-hydroxy-4-n-butyloxyphenyl)-6-(2,4-di-n-butyloxyphenyl)-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-nonyloxy-2-hydroxypropylox-y)-5-α-cumylphenyl]-s-triazine; methylenebis-{2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-butyloxy-2-hydroxypropoxy)phenyl]-s-triazine}; methylene bridged dimer mixture bridged in the 3:5', 5:5' and 3:3' positions in a 5:4:1 ratio; 2,4,6-tris(2-hydroxy-4-isooctyloxycarbonyliso-propylideneoxy-phenyl)-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-cumylphenyl)-s-triazine; 2-(2,4,6-trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4,6-tris[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)-phenyl]-s-triazine; mixture of 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy)phenyl)-s-triazine and 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy)phenyl)-s-triazine; 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4(3-(2-ethylhexyloxy)-2-hydroxypropoxy)-phenyl)-s-triazine; 4,6-diphenyl-2-(4-hexyloxy-2-hydroxyphenyl)-s-triazine; 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethylhexanoyloxy)ethoxy]phenol; 2,4,6-tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-triazine; propanoic acid, 2,2',2"-[1,3,5-triazine-2,4,6-triyltris[(3-hydroxy-4,1-phenylene)oxy]]tris-1,1',1" -trioctyl ester; propanoic acid, 2-[4-[4,6-bis([1,1'-biphenyl]-4-yl)-1,3,5-triazin-2yl]-3-hydroxyphenoxyl]-isooctyl ester; and combinations thereof.
    28. 28. A process according to embodiment 22, wherein the light stabilizer is a hindered amine light stabilizer according to embodiment 23 or embodiment 24, and an ultraviolet light absorber according to any one of embodiments 25-27.
    29. 29. A process according to any of the preceding embodiments, wherein the polymer composition further comprises at least one compound chosen from:

      a hydroxylamine compound according to Formula VIII:

      wherein

      T1 is chosen from C1-C36 hydrocarbyl, C5-C12 cycloalkyl, and C7-C9 aralkyl, optionally substituted; and

      T2 is chosen from hydrogen or T1; and

      a tertiary amine oxide compound according to Formula IX:

      wherein

      W1 and W2 are each independently chosen from a C6-C36 hydrocarbyl chosen from a straight or branched chain C6-C36 alkyl, C6-C12 aryl, C7-C36 aralkyl, C7-C36 alkaryl, C5-C36 cycloalkyl, C6-C36 alkcycloalkyl; and C6-C36 cycloalkylalkyl;

      W3 is chosen from a C1-C36 hydrocarbyl chosen from a straight or branched chain C1-C36 alkyl, C6-C12 aryl, C7-C36 aralkyl, C7-C36 alkaryl, C3-C36 cycloalkyl, C6-C36 alkcycloalkyl; and C6-C36 cycloalkylalkyl;

      with the proviso that at least one of W1, W2 and W3 contains a β carbon-hydrogen bond; and
      wherein said alkyl, aralkyl, alkaryl, cycloalkyl, alkcycloalkyl and cycloalkylalkyl groups may be interuppted by one to sixteen -O-, -S-, -SO-, -SO2-, -COO-, -OCO-, -CO-, -NW4-, -CONW4- and -NW4 CO- groups, or wherein said alkyl, aralkyl, alkaryl, cycloalkyl, alkcycloalkyl and cycloalkylallyl groups may be substituted by one to sixteen groups selected from -OW4, -SW4, -COOW4, -OCOW4, -COW4, -N(W4)2, -CON(W4)2, -NW4COW4 and 5- and 6-membered rings containing the -C(CH3)(CH2Rx)NL(CH2Rx)(CH3)C- group or wherein said alkyl, aralkyl, alkaryl, cycloalkyl, alkcycloalkyl and cycloalkylalkyl groups are both interuppted and substituted by the groups mentioned above; and
      wherein

      W4 is chosen from hydrogen or C1-C8 alkyl;

      Rx is chosen from hydrogen or methyl; and

      L is chosen from a C1-C30 alkyl, a --C(O)R moiety wherein R is a C1-C30 straight or branched chain alkyl group, or a --OR moiety wherein R is a C1-C30 straight or branched chain alkyl group; and
      wherein said aryl groups may be substituted by one to three halogen, C1-C8 alkyl, C1-C8 alkoxy or combinations thereof.

    30. 30. A process according to embodiment 29, wherein the compound according to Formula VIII is a N,N-dihydrocarbylhydroxylamine wherein T1 and T2 are independently chosen from benzyl, ethyl, octyl, lauryl, dodecyl, tetradecyl, hexadecyl, heptadecyl and octadecyl; or wherein T1 and T2 are each the alkyl mixture found in hydrogenated tallow amine.
    31. 31. A process according to embodiment 29 or embodiment 30, wherein the compound according to Formula VIII is a N,N-dihydrocarbylhydroxylamine chosen from: N,N-dibenzylhydroxylamine; N,N-diethylhydroxylamine; N,N-dioctylhydroxylamine; N,N-dilaurylhydroxylamine; N,N-didodecylhydroxylamine; N,N-ditetradecylhydroxylaamine; N,N-dihexadecylhydroxylamine; N,N-dioctadecylhydroxylamine; N-hexadecyl-N-tetradecylhydroxylamine; N-hexadecyl-N-heptadecylhydroxylamine; N-hexadecyl-N-octadecylhydroxylamine; N-heptadecyl-N-octadecylhydroxylamine; and N,N-di(hydrogenated tallow)hydroxylamine.
    32. 32. A process according to any of the preceding embodiments, wherein the polymer composition further comprises at least one compound chosen from co-additives; nucleating agents; fillers; reinforcing agents; polymer additives; and combinations thereof.
    33. 33. A process according to any of the preceding embodiments, wherein the stabilizer composition is present from 0.001 to 65.0 % by weight of the total weight of the polymer composition.
    34. 34. A process according to embodiment 33, wherein the stabilizer composition is present from 0.01 to 25 % by weight of the total weight of the polymer composition.
    35. 35. A process according to embodiment 33, wherein the stabilizer composition is present from 0.01 to 10 % by weight of the total weight of the polymer composition.
    36. 36. A process according to any one of the preceding embodiments further characterized in that the polymer composition remains stable and retains its optimal mechanical and/or physical properties over a longer period of time in the oven.
    37. 37. A stabilizer composition comprising:
      1. a) at least one compound chosen from the group of organic phosphites and phosphonites;
      2. b) at least one hindered phenol compound; and
      3. c) from 0.001 % to 5 % by weight of the total of at least one chroman-based compound according to Formula V:

        wherein

        R21 is a substituent that can be the same or different at from 0 to 4 positions of the aromatic portion of Formula V and is independently chosen from:

        C1-C12 hydrocarbyl;

        NR'R", wherein each of R' and R" is independently chosen from H and C1-C12 hydrocarbyl; and

        OR27, wherein R27 is chosen from: H; C1-C12 hydrocarbyl; COR'''; and Si(R28)3, wherein R''' is chosen from H and C1-C20 hydrocarbyl; and wherein R28 is chosen from C1-C12 hydrocarbyl and alkoxy;

        R22 is chosen from: H; and C1-C12 hydrocarbyl;

        R23 is chosen from H; and C1-C20 hydrocarbyl; and

        each of R24-R25 is independently chosen from: H; C1-C12 hydrocarbyl; and OR"", wherein R'''' is chosen from H and C1-C12 hydrocarbyl; and

        R26 is H, or a bond which together with R25 forms =O.

    38. 38. A stabilizer composition consisting of:
      1. a) at least one compound chosen from the group of organic phosphites and phosphonites;
      2. b) at least one hindered phenol compound; and
      3. c) at least one chroman-based compound according to Formula V:

        wherein

        R21 is a substituent that can be the same or different at from 0 to 4 positions of the aromatic portion of Formula V and is independently chosen from:

        C1-C12 hydrocarbyl;

        NR'R", wherein each of R' and R" is independently chosen from H and C1-C12 hydrocarbyl; and

        OR27, wherein R27 is chosen from: H; C1-C12 hydrocarbyl; COR'''; and Si(R28)3, wherein R''' is chosen from H and C1-C20 hydrocarbyl; and wherein R28 is chosen from C1-C12 hydrocarbyl and alkoxy;

        R22 is chosen from: H; and C1-C12 hydrocarbyl;

        R23 is chosen from H; and C1-C20 hydrocarbyl; and

        each of R24-R25 is independently chosen from: H; C1-C12 hydrocarbyl; and OR'''', wherein R'''' is chosen from H and C1-C12 hydrocarbyl; and

        R26 is H, or a bond which together with R25 forms =O.

    39. 39. A stabilizer composition according to embodiment 37 or embodiment 38, wherein R21 is present in at least one instance as OR27.
    40. 40. A stabilizer composition according to any one of embodiments 37 to 39, wherein the chroman-based compound is vitamin E or its acetate according to Formula Va

      wherein R21 is chosen from OH; and -OC(O)CH3, respectively.
    41. 41. A kit for stabilizing a polyolefin composition for use in a rotomolding process comprising in one or more containers a polymer-stabilizing amount of a stabilizer composition according to any one of embodiments 37 to 40.
    42. 42. A kit according to embodiment 41 further comprising in the same or an additional container one or more additive.
    43. 43. A rotomolded article:
      1. a) produced by a process according to any one of embodiments 1-36; or
      2. b) comprising a stabilizer composition according to any one of embodiments 37 to 40.

    Examples



    [0080] The following examples are provided to assist one skilled in the art to further understand certain embodiments of the present invention. These examples are intended for illustration purposes and are not to be construed as limiting the scope of the various embodiments of the present invention.

    Example 1 - Preparation of Polyolefin Hollow Articles Using the Rotational Molding Process



    [0081] 50 lb. batches of LLDPE formulated with any type of commercially available stabilizer additive package is dry blended and compounded at 190°C on a Davis Standard single screw extruder, with a 24:1 L/D screw with a mixing head running at 65 RPM. The resulting pellets are ground to rotomesh powder (less than 35 micron) on a Reduction Engineering pulverizor.

    [0082] Using enough resin to produce a 1/8" - 1/4" thick walled part, the formulation is rotationally molded using laboratory scale equipment (e.g., a Ferry E-40 shuttle rotational molder). The ground resin is placed in a cast aluminum mold, which is rotated biaxially in a gas fired oven heated to a temperature of 630° F (332° C). The arm ratio for the cast aluminum mold is 8:2. After rotating in the oven for specific time intervals, the mold is removed from the oven and air cooled for 13 minutes while still rotating, followed by a 2 minute water spray, and then 1 minute in circulating air. After the cooling cycle, the mold is opened and the hollow part is removed and then tested by measuring the mean failure energy (MFE) of the part. Sections can be cut from the part and then tested according to the "Dart Drop Low Temperature Impact Resistance Test Procedure," per American Rotational Molders (ARM).

    [0083] Formulations that achieve the highest mean fracture energy (MFE) at the shortest rotational molding time interval are desirable (reduced cycle time), as well as formulations that show retention of high MFE at longer cycle times (broad process window).

    [0084] The color (or yellowness) of the molded part can also be tested. Prior to the impact test, the impact specimen from the upper left corner is read for color. The sample is read using a GretagMacbeth Color i7 spectrophotometer. The yellowness according to ASTM D1925 is reported from the mold side of the roto molded part. Positive yellowness values indicates presence and magnitude of yellowness (generally unfavorable), while a negative yellowness value indicates that a material appears bluish (generally favorable).

    Example 2 - Preparation of Polyolefin Hollow Articles Using the Rotational Molding Process - (Comparative)



    [0085] Control and test samples are prepared and tested according to Example 1 above. The additive formulation for each sample is provided in Table 1 below.
    Table 1.
    SampleAdditive Formulation
    Control (high phenolic) 0.075 % CYANOX® 1790 (phenolic)
      0.06 % IRGAFOS® 168 (phosphite)
      0.035 % zinc stearate (co-stabilizer)
    Comparative 1 (invention) 0.0075 % CYANOX® 1790 (phenolic)
      0.06 % IRGAFOS® 168 (phosphite)
      0.05 % vitamin E (chroman-based compound)
      0.035 % zinc stearate (co-stabilizer)
    Comparative 2 (low phenolic) 0.0075 % CYANOX® 1790 (phenolic)
      0.06 % IRGAFOS® 168 (phosphite)
      0.035 % zinc stearate (co-stabilizer)


    [0086] In all cases the LLDPE resin contains 0.035% by weight of the total polymer composition of zinc stearate. The samples are rotomolded and tested according to the ARM procedure as described in Example 1. The stabilizer formulations of the present invention provide superior and unexpected properties compared to the state-of-the-art stabilizer formulations used in the rotomolding process. The mean failure energy (MFE) of the sample containing the stabilizer formulation according to the invention reached maximum MFE sooner than either of the control sample containing the typical commercial stabilizer system or the sample containing the low phenolic stabilizer system, and also maintained a higher MFE for a longer period of time than expected (Figure 1). Accordingly, the rotomolded LLDPE sample containing the stabilizer formulation according to the invention gave superior performance over both the control sample and the low phenolic sample.

    Example 3 - Preparation of Polyolefin Hollow Articles Using the Rotational Molding Process - (Comparative - Resin 1)



    [0087] Control and test samples are prepared and tested according to Example 1 above. The LLDPE resin is the same as in Example 2 (Resin 1). The additive formulation for each sample is provided in Table 2 below.
    Table 2.
    SampleAdditive Formulation
    Control 0.035 % IRGANOX® 3114 (phenolic antioxidant)
      0.11 % IRGAFOS® 168 (phosphite)
      0.035 % zinc stearate (co-stabilizer)
    Invention 0.06 % IRGAFOS® 168 (phosphite)
      0.05 % vitamin E acetate (chroman-based compound)
      0.035 % zinc stearate (co-stabilizer)


    [0088] The samples are rotomolded and tested according to the ARM procedure as described in Example 1, to 1/4" thickness. The stabilizer formulations of the present invention provide superior and unexpected properties compared to the state-of-the-art stabilizer formulations used in the rotomolding process. The mean failure energy (MFE) of the sample containing the stabilizer formulation according to the invention reached maximum MFE sooner than the control sample containing the typical commercial stabilizer system or the sample containing the low phenolic stabilizer system, and also maintained a higher MFE for a longer period of time than expected (Figure 2A). Accordingly, the rotomolded LLDPE sample containing the stabilizer formulation according to the invention gave superior performance over both the control sample and the low phenolic sample.

    [0089] The Yellowness Index is also tested. As seen in Figure 2B, the Yellowness Index remains relatively flat in the rotomolded part made with the stabilizer system according to the invention even as the peak internal air temperature rises. Conversely, the Yellowness Index rises as the peak internal air temperature rises in the Control sample.

    Example 4 - Preparation of Polyolefin Hollow Articles Using the Rotational Molding Process - (Comparative - Resin 2)



    [0090] Control and test samples are prepared and tested according to Example 1 above. However, in this Example the LLDPE resin (Resin 2) is provided by a different supplier than that of Examples 2 and 3. The additive formulation for each sample is provided in Table 3 below.
    Table 3.
    SampleAdditive Formulation
    Control 1 0.035 % IRGANOX® 3114 (phenolic antioxidant)
      0.09 % IRGAFOS® 168 (phosphite)
      0.035 % zinc stearate (co-stabilizer)
    Invention 0.06 % DOVERPHOS® 9228 (phosphite)
      0.05 % vitamin E acetate (chroman-based compound)
      0.05 % zinc stearate (co-stabilizer)
    Control 2 0.075 % CYANOX® 2777* (phenolic/phosphite)
      0.35 zinc stearate (co-stabilizer)
    * CYANOX® 2777 = CYANOX® 1790 (phenolic) + IRGAFOS® 168 (phosphite)


    [0091] The samples are rotomolded and tested according to the ARM procedure as described in Example 1, to 1/4" thickness. Again, it is seen that the stabilizer formulations of the present invention provide superior and unexpected properties compared to the state-of-the-art stabilizer formulations used in the rotomolding process. The mean failure energy (MFE) of the sample containing the stabilizer formulation according to the invention reached maximum MFE sooner than either of the control sample containing the typical commercial stabilizer system or the sample containing the low phenolic stabilizer system, and also maintained a higher MFE for a longer period of time than expected (Figure 3A). Accordingly, the rotomolded LLDPE sample containing the stabilizer formulation according to the invention gave superior performance over both the control samples.

    [0092] The Yellowness Index is also tested. As seen in Figure 3B, the Yellowness Index remains lower as the peak internal air temperature rises in the rotomolded part made with the stabilizer system according to the invention than with either of the control samples.

    [0093] The results demonstrate that the heating times required to achieve optimal cure of a polyolefin article using a standard rotomolding process can be reduced by using the processing stabilizer systems described in detail herein. Reduction of heating times provides the direct benefits of lower energy costs and increased production efficiency without compromising physical and/or mechanical properties of the rotomolded article. The new rotomolding processing stabilizer systems described herein are also shown to provide a broad processing window, thereby enabling the production of parts having high impact strength over a broader range of peak internal air temperatures or heating times versus conventional processing stabilizer systems. Accordingly, these new processing stabilizer systems provide an excellent alternative to other approaches and/or systems to accelerate the sintering/densification of the polymer resin during the rotomolding process.

    [0094] Various patent and/or scientific literature references have been referred to throughout this application. The disclosures of these publications in their entireties are hereby incorporated by reference as if written herein. In view of the above description and the examples, one of ordinary skill in the art will be able to practice the disclosure as claimed without undue experimentation.

    [0095] Although the foregoing description has shown, described, and pointed out the fundamental novel features of the present teachings, it will be understood that various omissions, substitutions, and changes in the form of the detail of the apparatus as illustrated, as well as the uses thereof, may be made by those skilled in the art.


    Claims

    1. Use of a composition comprising:

    i) at least one chroman-based compound selected from β-tocopherol; γ-tocopherol; δ-tocopherol; α-tocotrienol; β-tocotrienol; γ-tocotrienol; δ-tocotrienol; and vitamin E or its acetate according to Formula Va

    wherein R21 is chosen from OH; and -OC(O)CH3, respectively;

    and ii) at least one compound chosen from the group of organic phosphites or phosphonites;

    as a stabilizer composition in a polymer composition for producing a polymeric hollow article in a rotational molding process, wherein the stabilizer composition reduces the cycle time of said rotational molding process.
     
    2. The use of claim 1, the process comprising:

    a) filling a mold with a polymer composition and a polymer-stabilizing amount of said stabilizer composition;

    b) rotating the mold around at least 1 axis while heating the mold in an oven at a sufficient temperature to fuse the composition and spread it to the walls of the mold;

    c) cooling the mold; and

    d) opening the mold to remove the resulting product,

    thereby producing a polymeric hollow article.
     
    3. The use of claim 1 or claim 2, wherein the organic phosphite or phosphonite is chosen from: triphenyl phosphite; diphenyl alkyl phosphites; phenyl dialkyl phosphites; trilauryl phosphite; trioctadecyl phosphite; distearyl pentaerythritol phosphite; tris(2,4-di-tert-butylphenyl) phosphite; tris(nonylphenyl) phosphite; a compound of formulae (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) and (L):





















    2-butyl-2-ethyl-1,3-propanediol 2,4,6-tri-t-butylphenol phosphite; bis-(2,6-di-t-butyl-4-methlphenyl) pentaerythritol diphosphite; 2-butyl-2-ethyl-1,3-propanediol 2,4-di-cumylphenol phosphite; 2-butyl-2-ethyl-1,3-propanediol 4-methyl-2,6-di-t-butylphenol phosphite; bis-(2,4,6-tri-t-butyl-phenyl) pentaerythritol diphosphite; and combinations thereof.
     
    4. The use according to any one of claims 2 to 3, wherein the at least one organic phosphite or phosphonite is chosen from tris(2,4-di-tert-butylphenyl)phosphite (IRGAFOS® 168); Bis(2,4-dicumylphenyl)pentaerythritol diphosphite (DOVERPHOS® S9228); and tetrakis(2,4-di-tert-butylphenyl)4,4'-biphenylene-diphosphonite (IRGAFOS® P-EPQ).
     
    5. The use according to any one of claims 1 to 4, wherein the stabilizer composition further comprises at least one hindered phenol compound comprising a molecular fragment according to one or more of Formula (IVa), (IVb), or (IVc):

    wherein

    R18 in Formula (IVa), (IVb), and (IVc) is chosen from hydrogen or a C1-4 hydrocarbyl;

    each of R19 and R20 in Formula (IVa), (IVb), and (IVc) is independently chosen from hydrogen or a C1-C20 hydrocarbyl; and

    R37 in Formula (IVa), (IVb), and (IVc) is chosen from C1-C12 hydrocarbyl.


     
    6. The use according to claim 5, wherein R18 and R37 in Formula (IVa), (IVb), and (IVc) are independently chosen from methyl or t-butyl.
     
    7. The use according to any one of claims 5 to 6, wherein the at least one hindered phenol compound is chosen from: (1,3,5-Tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione; 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; 1,1,3-Tris(2'-methyl-4'-hydroxy-5'-t-butylphenyl)butane; Triethylene glycol bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionate]; 4,4'-Thiobis(2-t-butyl-5-methylphenol); 2,2'-Thiodiethylene bis[3-(3-t-butyl-4-hydroxyl-5-methylphenyl)propionate]; Octadecyl 3-(3'-t-butyl-4'-hydroxy-5'-methylphenyl)propionate; Tetrakismethylene(3-t-butyl-4-hydroxy-5-methylhydrocinnamate)methane; N,N'-Hexamethylene bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionamide]; Di(4-tertiarybutyl-3-hydroxy-2,6-dimethyl benzyl) thiodipropionate; and octadecyl 3,5-di-(tert)-butyl-4-hydroxyhydrocinnamate.
     
    8. The use according to any one of claims 1 to 7, wherein the chroman-based compound is selected from the group consisting of α-tocopherol acetate according to


     
    9. The use according to any one of claims 1 to 8, wherein the polymer composition comprises a polyolefin chosen from: i) polymers of monoolefins and diolefins chosen from polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, polyisoprene, and polybutadiene; ii) polymers of cycloolefins chosen from cyclopentene, and norbornene; iii) polyethylene chosen from optionally crosslinked polyethylene, high density polyethylene (HDPE), high density and high molecular weight polyethylene (HDPE-HMW), high density and ultrahigh molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), very low density polyethylene (VLDPE), and ultralow density polyethylene (ULDPE); iv) copolymers thereof; and v) mixtures thereof.
     
    10. The use according to any one of claims 1 to 9, wherein the polymer composition further comprises a light stabilizer chosen from: hindered amine light stabilizers, hindered hydroxyl benzoates, nickel phenolates, ultraviolet light stabilizers, and combinations thereof in an amount effective to stabilize the polymer composition against the degradative effects of visible and/or ultraviolet light radiation.
     
    11. The use according to claim 10, wherein the light stabilizer is a hindered amine light stabilizer compound comprising a molecular fragment according to Formula (VI):

    wherein

    R31 is chosen from: hydrogen; OH; C1-C20 hydrocarbyl; -CH2CN; C1-C12 acyl; or C1-C18 alkoxy;

    R38 is chosen from: hydrogen; or C1-C8 hydrocarbyl; and

    each of R29, R30, R32, and R33 is independently chosen from C1-C20 hydrocarbyl, or

    R29 and R30 and/or R32 and R33 taken together with the carbon to which they are attached form a C5-C10 cycloalkyl; or

    a molecular fragment according to Formula (VIa):

    wherein

    m is an integer from 1 to 2;

    R39 is chosen from: hydrogen; OH; C1-C20 hydrocarbyl; -CH2CN; C1-C12 acyl; or C1-C18 alkoxy; and

    each of G1-G4 is independently chosen from C1-C20 hydrocarbyl.


     
    12. The use according to claim 10 or claim 11, wherein the hindered amine light stabilizer is chosen from: bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate; bis(2,2,6,6-tetramethylpiperidin-4-yl)succinate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)sebacate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl) n-butyl 3,5-di-tert-butyl-4-hydroxybenzylmalonate; a condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid; 2,2,6,6-tetramethylpiperidin-4-yl stearate; 2,2,6,6-tetramethylpiperidin-4-yl dodecanate; 1,2,2,6,6-pentamethylpiperidin-4-yl stearate; 1,2,2,6,6-pentamethylpiperidin-4-yl dodecanate; a condensate ofN,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)- 1,2,3,4-butanetetracarboxylate; 4-benzoyl-2,2,6,6-tetramethylpiperidine; 4-stearyloxy-2,2,6,6-tetramethylpiperidine; bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinate; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine; a condensate of 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane; a condensate of 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1 ,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane; 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; a condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; a condensate of 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylpiperidine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane; oxo-piperanzinyl-triazines; a reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane and epichlorohydrin; tetrakis(2,2,6,6-tetramethyl-4-piperidyl) butane-1,2,3,4-tetracarboxylate; 1,2,3,4-butanetetracarboxylic acid, tetrakis(1,2,2,6,6-pentamethyl-4-piperidinyl)ester; 1,2,3,4-butanetetracarboxylic acid, 1,2,2,6,6-pentamethyl-4-piperdinyl tridecyl ester; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl tridecyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol,1,2,2,6,6-pentamethyl-4-piperdinyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol, 2,2,6,6-tetramethyl-4-piperdinyl ester; bis(1-undecanoxy-2,2,6,6-tetramethylpiperidin-4-yl)carbonate; 1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethyl-4-piperdinol; 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine; 1-(4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octadecanoyloxy-2-methylpropane; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperdinol; a reaction product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperdinol and dimethylsuccinate; 2,2,4,4-tetramethyl-7-oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one; the ester of 2,2,6,6-tetramethyl-4-piperidinol with higher fatty acids; 3-dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione; 1H-Pyrrole-2,5-dione, 1-octadecyl-, polymer with (1-methylethenyl)benzene and 1-(2,2,6,6-tetramethyl-4-piperidinyl)-1H-pyrrole-2,5-dione; piperazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris[3,3,5,5-tetramethyl-; piperazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris[3,3,4,5,5-pentamethyl-; the reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane and epichlorohydrin; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; the condensate of 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylpiperidine; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-morpholino-2,6-dichloro-1,3,5-triazine; the condensate of 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane; the condensate of 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane; 2-[(2-hydroxyethyl)amino]-4,6-bis[N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino-1,3,5-triazine; propanedioic acid, [(4-methoxyphenyl)-methylene]-bis-(1,2,2,6,6-pentamethyl-4-piperidinyl) ester; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 1-[2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4-piperidinyl ester; N-(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-N'-dodecyloxalamide; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl): 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(2,2,6,6-tetramethyl-4-piperidinyl); the condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid; the condensate of N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-1,3,5-triazine; 1,2,3,4-butanetetracarboxylic acid, 1,2,2,6,6-pentamethyl-4-piperidinyl tridecyl ester; tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl tridecyl ester; tetrakis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,2,3,4-butanetetracarboxylate; mixture of 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosane-20-propanoic acid-dodecylester and 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosane-20-propanoic acid-tetradecylester; 1H,4H,5H,8H-2,3a,4a,6,7a,8a-hexaazacyclopenta[def]fluorene-4,8-dione, hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-; polymethyl[propyl-3-oxy(2',2',6',6'-tetramethyl-4,4'-piperidinyl)]siloxane; polymethyl[propyl-3-oxy(1',2',2',6',6'-pentamethyl-4,4'-piperidinyl)]siloxane; copolymer of methylmethacrylate with ethyl acrylate and 2,2,6,6-tetramethylpiperidin-4-yl acrylate; copolymer of mixed C20 to C24 alpha-olefins and (2,2,6,6-tetramethylpiperidin-4-yl)succinimide; 1,2,3,4-butanetetracarboxylic acid, polymer with β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol, 1,2,2,6,6-pentamethyl-4-piperidinyl ester; 1,2,3,4-butanetetracarboxylic acid, polymer with β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol, 2,2,6,6-tetramethyl-4-piperidinyl ester copolymer; 1,3-benzenedicarboxamide, N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl; 1,1'-(1,10-dioxo-1,10-decanediyl)-bis(hexahydro-2,2,4,4,6-pentamethylpyrimidine; ethane diamide, N-(1-acetyl-2,2,6,6-tetramethylpiperidinyl)-N'-dodecyl; formamide, N,N'-1,6-hexanediylbis[N-(2,2,6,6-tetramethyl-4-piperidinyl); D-glucitol, 1,3:2,4-bis-O-(2,2,6,6-tetramethyl-4-piperidinylidene)-; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxo-dispiro[5.1.11.2]heneicosane; propanamide, 2-methyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)-2-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]-; 7-oxa-3,20-diazadispiro[5.1.11.2]heneicosane-20-propanoic acid, 2,2,4,4-tetramethyl-21-oxo-, dodecyl ester; N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-aminopropionic acid dodecyl ester; N-(2,2,6,6-tetramethylpiperidin-4-yl)-N'-aminooxalamide; propanamide, N-(2,2,6,6-tetramethyl-4-piperidinyl)-3-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]-; mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; bis(2,2,6,6-tetramethylpiperidin-4-yl)succinate; bis(1,2,2,6,6-pentamethylpiperidin-4-yl) n-butyl 3,5-di-tert-butyl-4-hydroxybenzylmalonate; tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate; 1,1'-(1,2-ethanediyl)bis(3,3,5,5-tetramethylpiperazinone); 4-benzoyl-2,2,6,6-tetramethylpiperidine; 4-stearyloxy-2,2,6,6-tetramethylpiperidine; bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinate; 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione; a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(2,2,6,6-tetramethyl-4-piperidinyl) and 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl); N1-(β-hydroxyethyl)3,3-pentamethylene-5,5-dimethylpiperazin-2-one; N1-tert-octyl-3,3,5,5-tetramethyl-diazepin-2-one; N1-tert-octyl-3,3-pentamethylene-5,5-hexamethylene-diazepin-2-one; N1-tert-octyl-3,3-pentamethylene-5,5-dimethylpiperazin-2-one; trans-1,2-cyclohexane-bis-(N1-5,5-dimethyl-3,3-pentamethylene-2-piperazinone; trans-1,2-cyclohexane-bis-(N1-3,3,5,5-dispiropentamethylene-2-piperazinone); N1-isopropyl-1,4-diazadispiro-(3,3,5,5)pentamethylene-2-piperazinone; N1-isopropyl-1,4-diazadispiro-3,3-pentamethylene-5,5-tetramethylene-2-piperazinone; N1-isopropyl-5,5-dimethyl-3,3-pentamethylene-2-piperazinone; trans-1,2-cyclohexane-bis-N1-(dimethyl-3,3-pentamethylene-2-piperazinone); N1-octyl-5,5-dimethyl-3,3-pentamethylene-1,4-diazepin-2-one; and N1-octyl-1,4-diazadispiro-(3,3,5,5)pentamethylene-1,5-diazepin-2-one.
     
    13. The use according to claim 10, wherein the light stabilizer is an ultraviolet light absorber chosen from a 2-hydroxybenzophenone compound, a 2-(2'-hydroxyphenyl)benzotriazole compound, a 2-(2'-hydroxyphenyl)-1,3,5-triazine compound, and combinations thereof.
     
    14. The use according to claim 13, wherein the ultraviolet light absorber is a 2-(2'-hydroxyphenyl)-1,3,5-triazine compound according to Formula (VII):

    wherein each of R34 and R35 is independently chosen from C6-C10 aryl optionally substituted, C1-C10 hydrocarbyl-substituted amino, C1-C10 acyl or C1-C10 alkoxyl; and wherein R36 is a substituent that is the same or different at from 0 to 4 positions of the phenoxy portion of Formula VII and is independently chosen from hydroxyl, C1-C12 hydrocarbyl, C1-C12 alkoxyl, C1-C12 alkoxyester, or C1-C12 acyl.
     
    15. The use according to claim 13 or claim 14, wherein the 2-(2'-hydroxyphenyl)-1,3,5-triazine compound is chosen from: 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-octyloxyphenyl)-s-triazine; 4,6-bis-(2,4-dimethylphenyl)-2-(2,4--dihydroxyphenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(4-chlorophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(4-chlorophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(4-bromophenyl)-s-triazine; 2,4-bis[2-hydroxy-4-(2-acetoxyethoxy)phenyl]-6-(4-chlorophenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethylideneoxy]phenyl]-s-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-s-triazine; 2-phenyl-4-[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)phenyl]-6-[2-hydroxy-4-(3-sec-amyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(- 3-benzyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4-bis(2-hydroxy-4-n-butyloxyphenyl)-6-(2,4-di-n-butyloxyphenyl)-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-nonyloxy-2-hydroxypropylox-y)-5-α-cumylphenyl]-s-triazine; methylenebis-{2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-butyloxy-2-hydroxypropoxy)phenyl]-s-triazine}; methylene bridged dimer mixture bridged in the 3:5', 5:5' and 3:3' positions in a 5:4:1 ratio; 2,4,6-tris(2-hydroxy-4-isooctyloxycarbonyliso-propylideneoxy-phenyl)-s-triazine; 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-cumylphenyl)-s-triazine; 2-(2,4,6-trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butyloxy-2-hydroxypropyloxy)phenyl]-s-triazine; 2,4,6-tris[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)-phenyl]-s-triazine; mixture of 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy)phenyl)-s-triazine and 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy)phenyl)-s-triazine; 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4(3-(2-ethylhexyloxy)-2-hydroxypropoxy)-phenyl)-s-triazine; 4,6-diphenyl-2-(4-hexyloxy-2-hydroxyphenyl)-s-triazine; 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethylhexanoyloxy)ethoxy]phenol; 2,4,6-tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-triazine; propanoic acid, 2,2',2"-[1,3,5-triazine-2,4,6-triyltris[(3-hydroxy-4, 1-phenylene)oxy]]tris-1,1',1"-trioctyl ester; propanoic acid, 2-[4-[4,6-bis([1,1'-biphenyl]-4-yl)-1,3,5-triazin-2yl]-3-hydroxyphenoxyl]-isooctyl ester; and combinations thereof.
     
    16. The use according to claim 10, wherein the light stabilizer is a hindered amine light stabilizer and an ultraviolet light absorber.
     
    17. The use according to any one of claims 1 to 16, wherein the polymer composition further comprises at least one compound chosen from co-additives; nucleating agents; fillers; reinforcing agents; polymer additives; and combinations thereof.
     
    18. The use according to any one of claims 1 to 17, wherein the stabilizer composition is present from 0.001 % to 65.0 % by weight of the total weight of the polymer composition; preferably from 0.01 to 25 % by weight of the total weight of the polymer composition; and more preferably from 0.01 to 10 % by weight of the total weight of the polymer composition.
     


    Ansprüche

    1. Verwendung einer Zusammensetzung, umfassend:

    i) mindestens eine auf Chroman basierende Zusammensetzung, ausgewählt aus β-Tocopherol, γ-Tocopherol, δ-Tocopherol, α-Tocotrienol, β-Tocotrienol, γ-Tocotrienol, δ-Tocotrienol und Vitamin E oder dessen Acetat gemäß Formel Va

    wobei R21 aus OH bzw. -OC(O)CH3 ausgewählt ist,

    und ii) mindestens eine Verbindung aus der Gruppe der organischen Phosphite oder Phosphonite,

    als Stabilisatorzusammensetzung in einer Polymerzusammensetzung zur Herstellung eines hohlen Polymergegenstands in einem Rotationsformverfahren, wobei die Stabilisatorzusammensetzung die Zykluszeit des Rotationsformverfahrens verkürzt.
     
    2. Verwendung nach Anspruch 1, wobei das Verfahren Folgendes umfasst:

    a) Füllen einer Form mit der Polymerzusammensetzung und einer polymerstabilisierenden Menge der Stabilisatorzusammensetzung,

    b) Drehen der Form um mindestens 1 Achse unter Erhitzen der Form in einem Ofen auf eine zum Schmelzen der Zusammensetzung und Ausbreiten der Zusammensetzung auf die Wände der Form ausreichen-de Temperatur,

    c) Abkühlen der Form und

    d) Öffnen der Form zur Entnahme des resultierenden Produkts, wodurch ein hohler Polymergegenstand erhalten wird.


     
    3. Verwendung nach Anspruch 1 oder Anspruch 2, wobei das organische Phosphit oder Phosphonit aus Triphenylphosphit, Diphenylalkylphosphiten, Phenyldialkylphosphiten, Trilaurylphosphit, Tri-octadecylphosphit, Distearylpentaerythritol-phosphit, Tris(2, 4-di-tert-butylphenyl) phosphit, Tris (nonylphenyl) phosphit, einer Verbindung der Formeln (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) und (L) :





















    2-Butyl-2-ethyl-1,3-propandiol-2,4,6-tri-t-butyl-phenolphosphit, Bis(2,6-di-t-butyl-4-methlphenyl)-pentaerythritoldiphosphit, 2-Butyl-2-ethyl-1,3-propandiol-2,4-dicumylphenolphosphit, 2-Butyl-2-ethyl-1,3-propandiol-4-methyl-2,6-di-t-butyl-phenolphosphit, Bis(2,4,6-tri-t-butylphenyl)pentaerythritoldiphosphit und Kombinationen davon ausgewählt ist.
     
    4. Verwendung nach einem der Ansprüche 2 bis 3, wobei das mindestens eine organische Phosphit oder Phosphonit aus Tris(2,4-di-tert-butylphenyl)-phosphit (IRGAFOS® 168), Bis(2,4-dicumylphenyl)-pentaerythritoldiphosphit (DOVERPHOS® S9228) und Tetrakis(2,4-di-tert-butylphenyl) 4,4'-biphenylendiphosphonit (IRGAFOS® P-EPQ) ausgewählt ist.
     
    5. Verwendung nach einem der Ansprüche 1 bis 4, wobei die Stabilisatorzusammensetzung ferner mindestens eine gehinderte Phenolverbindung umfasst, die ein Molekülfragment gemäß einer oder mehreren der Formeln (IVa), (IVb) oder (IVc) umfasst:

    wobei

    R18 in Formel (IVa), (IVb) und (IVc) aus Wasserstoff oder einem C1-4-Hydrocarbyl ausgewählt ist,

    R19 und R20 in Formel (IVa), (IVb) und (IVc) jeweils unabhängig aus Wasserstoff oder einem C1-C20-Hydrocarbyl ausgewählt sind und

    R37 in Formel (IVa), (IVb) und (IVc) aus C1-C12-Hydrocarbyl ausgewählt ist.


     
    6. Verwendung nach Anspruch 5, wobei R18 und R37 in Formel (IVa), (IVb) und (IVc) unabhängig aus Methyl oder t-Butyl ausgewählt sind.
     
    7. Verwendung nach einem der Ansprüche 5 bis 6, wobei die mindestens eine gehinderte Phenolverbindung aus 1,3,5-Tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazin-2,4,6-(1H,3H,5H)-trion, 1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazin-2,4,6(1H,3H,5H)-trion, 1,1,3-Tris-(2'-methyl-4'-hydroxy-5'-t-butylphenyl)butan, Triethylenglykolbis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionat], 4,4'-Thiobis(2-t-butyl-5-methylphenol), 2,2'-Thiodiethylenbis[3-(3-t-butyl-4-hydroxyl-5-methylphenyl)propionat], Octadecyl-3-(3'-t-butyl-4'-hydroxy-5'-methylphenyl)propionat, Tetrakismethylen(3-t-butyl-4-hydroxy-5-methylhydrocinnamat)methan, N,N'-Hexamethylenbis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionamid], Di(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)thiodipropionat und Octadecyl-3,5-di-(tert)-butyl-4-hydroxyhydrocinnamat ausgewählt ist.
     
    8. Verwendung nach einem der Ansprüche 1 bis 7, wobei die auf Chroman basierende Verbindung aus der Gruppe bestehend aus α-Tocopherolacetat gemäß

    ausgewählt ist.
     
    9. Verwendung nach einem der Ansprüche 1 bis 8, wobei die Polymerzusammensetzung ein Polyolefin umfasst, das aus i) Polymeren von Monoolefinen und Diolefinen, die aus Polypropylen, Polyisobutylen, Polybut-1-en, Poly-4-methylpent-1-en, Polyisopren oder Polybutadien ausgewählt sind, ii) Polymeren von Cycloolefinen, die aus Cyclopenten und Norbornen ausgewählt sind, iii) Polyethylen, das aus gegebenenfalls vernetztem Polyethylen, Polyethylen hoher Dichte (HDPE), hochmolekularem Polyethylen hoher Dichte (HDPE-HMW), ultrahochmolekularem Polyethylen hoher Dichte (HDPE-UHMW), Polyethylen mittlerer Dichte (MDPE), Polyethylen niedriger Dichte (LDPE), linearem Polyethylen niedriger Dichte (LLDPE), Polyethylen sehr niedriger Dichte (VLDPE) und Polyethylen ultraniedriger Dichte (ULDPE) ausgewählt ist, iv) Copolymeren davon und v) Mischungen davon ausgewählt ist.
     
    10. Verwendung nach einem der Ansprüche 1 bis 9, wobei die Polymerzusammensetzung ferner ein Lichtschutzmittel, das aus Lichtschutzmitteln vom Typ gehindertes Amin, gehinderten Hydroxylbenzoaten, Nickelphenolaten, Ultraviolett-Lichtschutzmitteln und Kombinationen davon ausgewählt ist, in einer zur Stabilisierung der Polymerzusammensetzung gegen die abbauenden Effekte von sichtbarer und/oder ultravioletter Lichtstrahlung wirksamen Menge umfasst.
     
    11. Verwendung nach Anspruch 10, wobei es sich bei dem Lichtschutzmittel um eine Lichtschutzmittelverbindung vom Typ gehindertes Amin mit einem Molekülfragment gemäß Formel (VI):

    wobei

    R31 aus Wasserstoff, OH, C1-C20-Hydrocarbyl, -CH2CN, C1-C12-Acyl oder C1-C18-Alkoxy ausgewählt ist,

    R38 aus Wasserstoff oder C1-C8-Hydrocarbyl ausgewählt ist und

    R29, R30, R32 und R33 jeweils unabhängig aus C1-C20-Hydrocarbyl ausgewählt sind oder

    R29 und R30 und/oder R32 und R33 zusammen mit dem Kohlenstoff, an den sie gebunden sind, ein C5-C10-Cycloalkyl bilden, oder

    einem Molekülfragment gemäß Formel (VIa):

    wobei

    m für eine ganze Zahl von 1 bis 2 steht,

    R39 aus Wasserstoff, OH, C1-C20-Hydrocarbyl, -CH2CN, C1-C12-Acyl oder C1-C18-Alkoxy ausgewählt ist und G1-G4 jeweils unabhängig aus C1-C20-Hydrocarbyl ausgewählt sind,

    handelt.
     
    12. Verwendung nach Anspruch 10 oder Anspruch 11, wobei das Lichtschutzmittel vom Typ gehindertes Amin aus Bis(2,2,6,6-tetramethylpiperidin-4-yl)sebacat, Bis(2,2,6,6-tetramethylpiperidin-4-yl)succinat, Bis(1,2,2,6,6-pentamethylpiperidin-4-yl)sebacat, Bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)sebacat, Bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-n-butyl-3,5-di-tert-butyl-4-hydroxybenzylmalonat, einem Kondensat von 1-(2-Hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidin und Bernsteinsäure, 2,2,6,6-Tetramethylpiperidin-4-ylstearat, 2,2,6,6-Tetramethylpiperidin-4-yldodecanat, 1,2,2,6,6-Pentamethylpiperidin-4-ylstearat, 1,2,2,6,6-Pentamethylpiperidin-4-yldodecanat, einem Kondensat von N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylendiamin und 4-tert-Octylamino-2,6-dichlor-1,3,5-triazin, Tris(2,2,6,6-tetramethylpiperidin-4-yl)nitrilotriacetat, Tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butantetracarboxylat, 4-Benzoyl-2,2,6,6-tetramethylpiperidin, 4-Stearyloxy-2,2,6,6-tetramethylpiperidin, Bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonat, 3-n-Octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dion, Bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacat, Bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinat, einem Kondensat von N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylendiamin und 4-Morpholino-2,6-dichlor-1,3,5-triazin, einem Kondensat von 2-Chlor-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazin und 1,2-Bis(3-aminopropylamino)ethan, einem Kondensat von 2-Chlor-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazin und 1,2-Bis(3-aminopropylamino)ethan, 8-Acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dion, 3-Dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dion, 3-Dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dion, 3-Dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidin-2,5-dion, einem Gemisch von 4-Hexadecyloxy- und 4-Stearyloxy-2,2,6,6-tetramethylpiperidin, einem Kondensat von N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylendiamin und 4-Cyclohexylamino-2,6-dichlor-1,3,5-triazin, einem Kondensat von 1,2-Bis(3-aminopropylamino)ethan, 2,4,6-Trichlor-1,3,5-triazin und 4-Butylamino-2,2,6,6-tetramethylpiperidin, 2-Undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decan, Oxopiperazinyltriazinen, einem Reaktionsprodukt von 7,7,9,9-Tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decan und Epichlorhydrin, Tetrakis(2,2,6,6-tetramethyl-4-piperidyl)butan-1,2,3,4-tetracarboxylat, 1,2,3,4-Butantetracarbonsäuretetrakis(1,2,2,6,6-pentamethyl-4-piperidinyl)ester, 1,2,3,4-Butantetracarbonsäure-1,2,2,6,6-pentamethyl-4-piperdinyltridecylester, 1,2,3,4-Butantetracarbonsäure-2,2,6,6-tetramethyl-4-piperidinyltridecylester, 1,2,3,4-Butantetracarbonsäure, Polymer mit 2,2,6,6-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecan-3,9-diethanol, 1,2,2,6,6-Pentamethyl-4-piperidinylester, 1,2,3,4-Butantetracarbonsäure, Polymer mit 2,2,6,6-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecan-3,9-diethanol, 2,2,6,6-Tetramethyl-4-piperidinylester, Bis(1-undecanoxy-2,2,6,6-tetramethylpiperidin-4-yl)carbonat, 1-(2-Hydroxy-2-methylpropoxy)-2,2,6,6-tetramethyl-4-piperidinol, 1-(2-Hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin, 1-(4-Octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octadecanoyloxy-2-methylpropan, 1-(2-Hydroxyethyl)-2,2,6,6-tetramethyl-4-piperidinol, einem Reaktionsprodukt von 1-(2-Hydroxyethyl)-2,2,6,6-tetramethyl-4-piperidinol und Dimethylsuccinat, 2,2,4,4-Tetramethyl-7-oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-on, einem Ester von 2,2,6,6-Tetramethyl-4-piperidinol mit höheren Fettsäuren, 3-Dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidin-2,5-dion, 1-Octadecyl-1H-pyrrol-2,5-dion, Polymer mit (1-Methylethenyl)benzol und 1-(2,2,6,6-Tetramethyl-4-piperidinyl)-1H-pyrrol-2,5-dion, 1,1',1"-[1,3,5-Triazin-2,4,6-triyltris[(cyclohexylimino)-2,1-ethandiyl]]tris[3,3,5,5-tetramethylpiperazinon, 1,1',1"-[1,3,5-Triazin-2,4,6-triyltris[(cyclohexylimino)-2,1-ethandiyl]]tris[3,3,4,5,5-pentamethylpiperazinon, dem Reaktionsprodukt von 7,7,9,9-Tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decan und Epichlorhydrin, dem Kondensat von N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylendiamin und 4-Cyclohexylamino-2,6-dichlor-1,3,5-triazin, dem Kondensat von 1,2-Bis(3-aminopropylamino)ethan, 2,4,6-Trichlor-1,3,5-triazin und 4-Butylamino-2,2,6,6-tetramethylpiperidin, dem Kondensat von N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylendiamin und 4-Morpholino-2,6-dichlor-1,3,5-triazin, dem Kondensat von 2-Chlor-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1,3,5-triazin und 1,2-Bis(3-aminopropylamino)ethan, dem Kondensat von 2-Chlor-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazin und 1,2-Bis(3-aminopropylamino)ethan, 2-[(2-Hydroxyethyl)amino]-4,6-bis[N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino-1,3,5-triazin, Propandisäure[(4-methoxyphenyl)methylen]bis(1,2,2,6,6-pentamethyl-4-piperidinyl)ester, Tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butantetracarboxylat, 3,5-Bis(1,1-dimethylethyl)-4-hydroxybenzolpropansäure-1-[2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4-piperidinylester, N-(1-Octyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-N'-dodecyloxalamid, Tris(2,2,6,6-tetramethylpiperidin-4-yl)nitrilotriacetat, 1,5-Dioxaspiro{5,5}undecan-3,3-dicarbonsäurebis(1,2,2,6,6-pentamethyl-4-piperidinyl), 1,5-Dioxaspiro{5,5}undecan-3,3-dicarbonsäurebis(2,2,6,6-tetramethyl-4-piperidinyl), dem Kondensat von 1-(2-Hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidin und Bernsteinsäure, dem Kondensat von N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylendiamin und 4-tert-Octylamino-2,6-dichlor-1,3,5-triazin, 1,2,3,4-Butantetracarbonsäure-1,2,2,6,6-pentamethyl-4-piperidinyltridecylester, Tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3,4-butantetracarboxylat, 1,2,3,4-Butantetracarbonsäure-2,2,6,6-tetramethyl-4-piperidinyltridecylester, Tetrakis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,2,3,4-butantetracarboxylat, einem Gemisch von 2,2,4,4-Tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosan-20-propansäuredodecylester und 2,2,4,4-Tetramethyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-heneicosan-20-propansäuretetradecylester, Hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-1H,4H,5H,8H-2,3a,4a,6,7a,8a-hexaazacyclopenta[def]fluoren-4,8-dion, Polymethyl[propyl-3-oxy(2',2',6',6'-tetramethyl-4,4'-piperidinyl)]siloxan, Polymethyl[propyl-3-oxy(1',2',2',6',6'-pentamethyl-4,4'-piperidinyl)]siloxan, einem Copolymer von Methylmethacrylat mit Ethylacrylat und 2,2,6,6-Tetramethylpiperidin-4-ylacrylat, einem Copolymer von gemischten C20- bis C24-alpha-Olefinen und (2,2,6,6-Tetramethylpiperidin-4-yl)succinimid, 1,2,3,4-Butantetracarbonsäure, Polymer mit β,β,β',β'-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecan-3,9-diethanol, 1,2,2,6,6-Pentamethyl-4-piperidinylester, 1,2,3,4-Butantetracarbonsäure, Polymer mit β,β,β',β'-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecan-3,9-diethanol, 2,2,6,6-Tetramethyl-4-piperidinylester-Copolymer, N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl-1,3-benzoldicarboxamid, 1,1'-(1,10-Dioxo-1,10-decandiyl)bis(hexahydro-2,2,4,4,6-pentamethylpyrimidin, N-(1-Acetyl-2,2,6,6-tetramethylpiperidinyl)-N'-dodecylethandiamid, N,N'-1,6-Hexandiylbis[N-(2,2,6,6-tetramethyl-4-piperidinyl)formamid, 1,3:2,4-Bis-O-(2,2,6,6-tetramethyl-4-piperidinyliden)-D-glucitol, 2,2,4,4-Tetramethyl-7-oxa-3,20-diaza-21-oxodispiro[5.1.11.2]heneicosan, 2-Methyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)-2-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]propanamid, 7-Oxa-3,20-diazadispiro[5.1.11.2]heneicosan-20-propansäure-2,2,4,4-tetramethyl-21-oxododecylester, N-(2,2,6,6-Tetramethylpiperidin-4-yl)-β-aminopropionsäuredodecylester, N-(2,2,6,6-Tetramethylpiperidin-4-yl)-N'-aminooxalamid, N-(2,2,6,6-Tetramethyl-4-piperidinyl)-3-[(2,2,6,6-tetramethyl-4-piperidinyl)amino]propanamid, einem Gemisch von 4-Hexadecyloxy- und 4-Stearyloxy-2,2,6,6-tetramethylpiperidin, 3-Dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidin-2,5-dion, 3-Dodecyl-1-(1-ethanoyl-2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidin-2,5-dion, Bis(2,2,6,6-tetramethylpiperidin-4-yl)succinat, Bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-n-butyl-3,5-di-tert-butyl-4-hydroxybenzylmalonat, Tris(2,2,6,6-tetramethylpiperidin-4-yl)nitrilotriacetat, 1,1'-(1,2-Ethandiyl)bis(3,3,5,5-tetramethylpiperazinon), 4-Benzoyl-2,2,6,6-tetramethylpiperidin, 4-Stearyloxy-2,2,6,6-tetramethylpiperidin, Bis(1,2,2,6,6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonat, 3-n-Octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dion, Bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)sebacat, Bis(1-octyloxy-2,2,6,6-tetramethylpiperidyl)succinat, 8-Acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decan-2,4-dion, 3-Dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dion, 3-Dodecyl-1-(1-ethanoyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dion, 3-Dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidin-2,5-dion, einem Gemisch von 4-Hexadecyloxy- und 4-Stearyloxy-2,2,6,6-tetramethylpiperidin, 2-Undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decan, Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,5-dioxaspiro{5,5}undecan-3,3-dicarbonsäure und Bis(1,2,2,6,6-pentamethyl-4-piperidinyl)-1,5-dioxaspiro{5,5}undecan-3,3-dicarbonsäure, N1-(β-Hydroxyethyl)-3,3-pentamethylen-5,5-dimethylpiperazin-2-on, N1-tert-Octyl-3,3,5,5-tetramethyldiazepin-2-on, N1-tert-Octyl-3,3-pentamethylen-5,5-hexamethylendiazepin-2-on, N1-tert-Octyl-3,3-pentamethylen-5,5-dimethylpiperazin-2-on, trans-1,2-Cyclohexanbis(N1-5,5-dimethyl-3,3-pentamethylen-2-piperazinon, trans-1,2-Cyclohexanbis(N1-3,3,5,5-dispiropentamethylen-2-piperazinon), N1-Isopropyl-1,4-diazadispiro-(3,3,5,5)pentamethylen-2-piperazinon, N1-Isopropyl-1,4-diazadispiro-3,3-pentamethylen-5,5-tetramethylen-2-piperazinon, N1-Isopropyl-5,5-dimethyl-3,3-pentamethylen-2-piperazinon, trans-1,2-Cyclohexanbis-N1-(dimethyl-3,3-pentamethylen-2-piperazinon), N1-Octyl-5,5-dimethyl-3,3-pentamethylen-1,4-diazepin-2-on und N1-Octyl-1,4-diazadispiro(3,3,5,5)pentamethylen-1,5-diazepin-2-on ausgewählt ist.
     
    13. Verwendung nach Anspruch 10, wobei es sich bei dem Lichtschutzmittel um einen Ultraviolettlichtabsorber handelt, der aus einer 2-Hydroxybenzophenonverbindung, einer 2-(2'-Hydroxyphenyl)-benzotriazolverbindung, einer 2-(2'-Hydroxyphenyl)-1,3,5-triazinverbindung und Kombinationen davon ausgewählt ist.
     
    14. Verwendung nach Anspruch 13, wobei es sich bei dem Ultraviolettlichtabsorber um eine 2-(2'-Hydroxyphenyl)-1,3,5-triazinverbindung gemäß Formel (VII) handelt:

    wobei R34 und R35 jeweils unabhängig aus gegebenenfalls substituiertem C6-C10-Aryl, C1-C10-hydrocarbylsubstituiertem Amino, C1-C10-Acyl oder C1-C10-Alkoxyl ausgewählt sind und wobei R36 für einen Substituenten steht, der an 0 bis 4 Positionen des Phenoxy-Teils der Formel VII gleich oder verschieden ist und unabhängig aus Hydroxyl, C1-C12-Alkyl, C1-C12-Alkoxyl, C1-C12-Alkoxyester oder C2-C12-Acyl ausgewählt ist.
     
    15. Verwendung nach Anspruch 13 oder Anspruch 14, wobei die 2-(2'-Hydroxyphenyl)-1,3,5-triazinverbindung aus 4,6-Bis(2,4-dimethylphenyl)-2-(2-hydroxy-4-octyloxyphenyl)-s-triazin, 4,6-Bis(2,4-dimethylphenyl)-2-(2,4-dihydroxyphenyl)-s-triazin, 2,4-Bis(2,4-dihydroxyphenyl)-6-(4-chlorphenyl)-s-triazin, 2,4-Bis[2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(4-chlorphenyl)-s-triazin, 2,4-Bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(2,4-dimethylphenyl)-s-triazin, 2,4-Bis[2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(4-bromphenyl)-s-triazin, 2,4-Bis[2-hydroxy-4-(2-acetoxyethoxy)phenyl]-6-(4-chlorphenyl)-s-triazin, 2,4-Bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-s-triazin, 2,4-Bis(4-biphenylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethylidenoxy]phenyl]-s-triazin, 2,4-Bis(4-biphenylyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-s-triazin, 2-Phenyl-4-[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)phenyl]-6-[2-hydroxy-4-(3-sec-amyloxy-2-hydroxypropyloxy)phenyl]-s-triazin, 2,4-Bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(-3-benzyloxy-2-hydroxypropyloxy)phenyl]-s-triazin, 2,4-Bis(2-hydroxy-4-n-butyloxyphenyl)-6-(2,4-di-n-butyloxyphenyl)-s-triazin, 2,4-Bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-nonyloxy-2-hydroxypropyloxy)-5-α-cumylphenyl]-s-triazin, Methylenbis-{2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-butyloxy-2-hydroxypropoxy)phenyl]-s-triazin}, einem Gemisch von methylenverbrückten Dimeren, die in den 3:5'-, 5:5'- und 3:3'-Positionen verbrückt sind, im Verhältnis 5:4:1, 2,4,6-Tris(2-hydroxy-4-isooctyloxycarbonylisopropylidenoxy-phenyl)-s-triazin, 2,4-Bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-cumylphenyl)-s-triazin, 2-(2,4,6-Trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butyloxy-2-hydroxypropyloxy)phenyl]-s-triazin, 2,4,6-Tris[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)-phenyl]-s-triazin, einem Gemisch von 4,6-Bis(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy)phenyl)-s-triazin und 4,6-Bis(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy)phenyl)-s-triazin, 4,6-Bis(2,4-dimethylphenyl)-2-(2-hydroxy-4(3-(2-ethylhexyloxy)-2-hydroxypropoxy)-phenyl)-s-triazin, 4,6-Diphenyl-2-(4-hexyloxy-2-hydroxyphenyl)-s-triazin, 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethylhexanoyloxy)ethoxy]phenol, 2,4,6-Tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-triazin, Propansäure-2,2',2''-[1,3,5-triazin-2,4,6-triyltris[(3-hydroxy-4,1-phenylen)oxy]]tris-1,1',1"-trioctylester, Propansäure-2-[4-[4,6-bis([1,1'-biphenyl]-4-yl)-1,3,5-triazin-2-yl]-3-hydroxyphenoxyl]-isooctylester und Kombinationen davon ausgewählt ist.
     
    16. Verwendung nach Anspruch 10, wobei es sich bei dem Lichtschutzmittel um ein Lichtschutzmittel vom Typ gehindertes Amin und einen Ultraviolettlichtabsorber handelt.
     
    17. Verwendung nach einem der Ansprüche 1 bis 16, wobei die Copolymerzusammensetzung ferner mindestens eine Verbindung umfasst, die aus Coadditiven, Nukleierungsmitteln, Füllstoffen, Verstärkungsmitteln, Polymeradditiven und Kombinationen davon ausgewählt ist.
     
    18. Verwendung nach einem der Ansprüche 1 bis 17, wobei die Stabilisatorzusammensetzung in einer Menge von 0,001 bis 65,0 Gew.-% des Gesamtgewichts der Polymerzusammensetzung, vorzugsweise von 0,01 bis 25 Gew.-% des Gesamtgewichts der Polymerzusammensetzung und weiter bevorzugt von 0,01 bis 10 Gew.-% des Gesamtgewichts der Polymerzusammensetzung vorliegt.
     


    Revendications

    1. Utilisation d'une composition comprenant :

    i) au moins un composé à base de chromane choisi parmi β-tocophérol ; γ-tocophérol ; δ-tocophérol ; α-tocotriénol ; β-tocotriénol ; γ-tocotriénol ; δ-tocotriénol ; et vitamine E ou son acétate répondant à la Formule Va

    dans laquelle R21 est respectivement choisi parmi OH ; et -OC(O)CH3 ;

    et ii) au moins un composé choisi dans le groupe constitué par les phosphites ou phosphonites organiques ;

    en tant que composition de stabilisant dans une composition de polymère pour la production d'un article creux polymère dans un procédé de moulage par rotation, dans laquelle la composition de stabilisant réduit la durée de cycle dudit procédé de moulage par rotation.
     
    2. Utilisation selon la revendication 1, le procédé comprenant :

    a) le remplissage d'un moule avec une composition de polymère et une quantité stabilisant le polymère de ladite composition de stabilisant ;

    b) la rotation du moule autour d'au moins 1 axe tout en chauffant le moule dans un four à une température suffisante pour faire fondre la composition et la répartir sur les parois du moule ;

    c) le refroidissement du moule ; et

    d) l'ouverture du moule pour retirer le produit résultant,

    pour obtenir ainsi un article creux polymère.
     
    3. Utilisation selon la revendication 1 ou la revendication 2, dans laquelle le phosphite ou phosphonite organique est choisi parmi : triphénylphosphite ; diphénylalkylphosphites ; phényldialkylphosphites ; trilaurylphosphite ; trioctadécylphosphite ; distéarylpentaérythritolphosphite ; tris(2,4-di-tert-butylphényl)phosphite ; tris(nonylphényl)phosphite ; un composé de formule (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) et (L) :





















    2-butyl-2-éthyl-1,3-propanediol-2,4,6-tri-t-butylphénolphosphite ; bis-(2,6-di-t-butyl-4-méthlphényl)pentaérythritoldiphosphite ; 2-butyl-2-éthyl-1,3-propanediol-2,4-di-cumylphénolphosphite ; 2-butyl-2-éthyl-1,3-propanediol-4-méthyl-2,6-di-t-butylphénolphosphite ; bis-(2,4,6-tri-t-butylphényl)pentaérythritoldiphosphite ; et les combinaisons de ceux-ci.
     
    4. Utilisation selon l'une quelconque des revendications 2 à 3, dans laquelle l'au moins un phosphite ou phosphonite organique est choisi parmi tris(2,4-di-tert-butylphényl)phosphite (IRGAFOS® 168) ; bis(2,4-dicumylphényl)pentaérythritoldiphosphite (DOVERPHOS® S9228) ; et tétrakis(2,4-di-tert-butylphényl)4,4'-biphénylène-diphosphonite (IRGAFOS® P-EPQ) .
     
    5. Utilisation selon l'une quelconque des revendications 1 à 4, dans laquelle la composition de stabilisant comprend en outre au moins un phénol encombré comprenant un fragment moléculaire répondant à une ou plusieurs des Formules (IVa), (IVb), ou (IVc) :

    dans laquelle

    R18 dans les Formules (IVa), (IVb), et (IVc) est choisi parmi un hydrogène ou un hydrocarbyle en C1-4 ;

    chacun des radicaux R19 et R20 dans les Formules (IVa), (IVb), et (IVc) est indépendamment choisi parmi un hydrogène ou un hydrocarbyle en C1-C20 ; et

    R37 dans les Formules (IVa), (IVb) et (IVc) est choisi parmi un hydrocarbyle en C1-C12.


     
    6. Utilisation selon la revendication 5, dans laquelle R18 et R37 dans les Formules (IVa), (IVb) et (IVc) sont indépendamment choisis parmi un méthyle ou un t-butyle.
     
    7. Utilisation selon l'une quelconque des revendications 5 à 6, dans laquelle l'au moins un phénol encombré est choisi parmi : (1,3,5-tris(4-t-butyl-3-hydroxy-2,6-diméthylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione ; 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione ; 1,1,3-tris(2'-méthyl-4'-hydroxy-5'-t-butylphényl)butane ; bis[3-(3-t-butyl-4-hydroxy-5-méthylphényl)propionate] de triéthylène glycol ; 4,4'-thiobis(2-t-butyl-5-méthylphénol) ; bis[3-(3-t-butyl-4-hydroxyl-5-méthylphényl)propionate] de 2,2'-thiodiéthylène ; 3-(3'-t-butyl-4'-hydroxy-5'-méthylphényl)propionate d'octadécyle ; tétrakisméthylenc(3-t-butyl-4-hydroxy-5-méthylhydrocinnamate)méthane ; N,N'-hexaméthylène bis[3-(3-t-butyl-4-hydroxy-5-méthylphényl)propionamide] ; thiodipropionate de di(4-tert-butyl-3-hydroxy-2,6-diméthylbenzyle) ; et 3,5-di-(tert)-butyl-4-hydroxyhydrocinnamate d'octadécyle.
     
    8. Utilisation selon l'une quelconque des revendications 1 à 7, dans laquelle le composé à base de chromane est choisi dans le groupe constitué par l'acétate d'a-tocophérol répondant à


     
    9. Utilisation selon l'une quelconque des revendications 1 à 8, dans laquelle la composition de polymère comprend une polyoléfine choisie parmi : i) les polymères de mono-oléfines et de dioléfines choisis parmi polypropylène, polyisobutylène, polybut-1-ène, poly-4-méthylpent-1-ène, polyisoprène, et polybutadiène ; ii) les polymères de cyclooléfines choisis parmi cyclopentène, et norbornène ; iii) le polyéthylène choisi parmi polyéthylène éventuellement réticulé, polyéthylène haute densité (HDPE), polyéthylène haute densité et de masse moléculaire élevée (HDPE-HMW), polyéthylène haute densité et de masse moléculaire ultra-élevée (HDPE-UHMW), polyéthylène de densité moyenne (MDPE), polyéthylène basse densité (LDPE), polyéthylène basse densité linéaire (LLDPE), polyéthylène très basse densité (VLDPE), et polyéthylène ultrabasse densité (ULDPE) ; iv) les copolymères de ceux-ci ; et v) les mélanges de ceux-ci.
     
    10. Utilisation selon l'une quelconque des revendications 1 à 9, dans laquelle la composition de polymère comprend en outre un photostabilisant choisi parmi : les photostabilisants de type amine encombrée, les hydroxylbenzoates encombrés, les phénolates de nickel, les photostabilisants ultraviolets, et les combinaisons de ceux-ci à une teneur permettant de stabiliser la composition de polymère vis-à-vis des effets dégradants des rayonnements lumineux visibles et/ou ultraviolets.
     
    11. Utilisation selon la revendication 10, dans laquelle le photostabilisant est un composé photostabilisant de type amine encombrée comprenant un fragment moléculaire répondant à la Formule (VI) :

    dans laquelle

    R31 est choisi parmi : un hydrogène ; OH ; un hydrocarbyle en C1-C20 ; -CH2CN ; un acyle en C1-C12 ; ou un alkoxy en C1-C18 ;

    R38 est choisi parmi : un hydrogène ; ou un hydrocarbyle en C1-C8 ; et

    chacun de R29, R30, R32, et R33 est indépendamment choisi parmi un hydrocarbyle en C1-C20, ou

    R29 et R30 et/ou R32 et R33 forment conjointement avec le carbone auquel ils sont liés un cycloalkyle en C5-C10 ; ou

    un fragment moléculaire répondant à la Formule (VIa) :

    dans laquelle

    m représente un entier compris entre 1 et 2 ;

    R39 est choisi parmi : un hydrogène ; OH ; un hydrocarbyle en C1-C20 ; -CH2CN ; un acyle en C1-C12 ; ou un alkoxy en C1-C18 ; et

    chacun des radicaux G1 à G4 est indépendamment choisi parmi un hydrocarbyle en C1-C20.


     
    12. Utilisation selon la revendication 10 ou la revendication 11, dans laquelle le photostabilisant de type amine encombrée est choisi parmi : sébacate de bis(2,2,6,6-tétraméthylpipéridin-4-yle) ; succinate de bis(2,2,6,6-tétraméthylpipéridin-4-yle) ; sébacate de bis(1,2,2,6,6-pentaméthylpipéridin-4-yle) ; sébacate de bis(1-octyloxy-2,2,6,6-tétraméthylpipéridin-4-yle) ; 3,5-di-tert-butyl-4-hydroxybenzylmalonate de bis(1,2,2,6,6-pentaméthylpipéridin-4-yle)-n-butyle ; un condensat de 1-(2-hydroxyéthyl)-2,2,6,6-tétraméthyl-4-hydroxypipéridine et d'acide succinique ; stéarate de 2,2,6,6-tétraméthylpipéridin-4-yle ; dodécanate de 2,2,6,6-tétraméthylpipéridin-4-yle ; stéarate de 1,2,2,6,6-pentaméthylpipéridin-4-yle ; dodécanate de 1,2,2,6,6-pentaméthylpipéridin-4-yle ; un condensat de N,N'-bis (2,2,6,6-tétraméthylpipéridin-4-yl)hexaméthylènediamine et de 4-tert-octylamino-2,6-dichloro-1,3,5-triazine ; nitrilotriacétate de tris(2,2,6,6-tétraméthylpipéridin-4-yle) ; 1,2,3,4-butanetétracarboxylate de tétrakis(2,2,6,6-tétraméthylpipéridin-4-yle) ; 4-benzoyl-2,2,6,6-tétraméthylpipéridine ; 4-stéaryloxy-2,2,6,6-tétraméthylpipéridine ; 2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate de bis(1,2,2,6,6-pentaméthylpipéridyl)-2-n-butyle ; 3-n-octyl-7,7,9,9-tétraméthyl-1,3,8-triazaspiro[4.5]décan-2,4-dione ; sébacate de bis(1-octyloxy-2,2,6,6-tétraméthylpipéridyle) ; succinate de bis(1-octyloxy-2,2,6,6-tétraméthylpipéridyle) ; un condensat de N,N'-bis(2,2,6,6-tétraméthylpipéridin-4-yl)hexaméthylènediamine et de 4-morpholino-2,6-dichloro-1,3,5-triazine ; un condensat de 2-chloro-4,6-bis(4-n-butylamino- 2,2,6,6-tétraméthylpipéridyl)-1,3,5-triazine et de 1,2-bis(3-aminopropylamino)éthane ; un condensat de 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentaméthylpipéridyl)-1,3,5-triazine et de 1,2-bis-(3-aminopropylamino)éthane ; 8-acétyl-3-dodécyl-7,7,9,9-tétraméthyl-1,3,8-triazaspiro[4.5]décane-2,4-dione ; 3-dodécyl-1-(2,2,6,6-tétraméthylpipéridin-4-yl)pyrrolidin-2,5-dione ; 3-dodécyl-1-(1-éthanoyl-2,2,6,6-tétraméthylpipéridin-4-yl)pyrrolidin-2,5-dione ; 3-dodécyl-1-(1,2,2,6,6-pentaméthylpipéridin-4-yl)pyrrolidine-2,5-dione ; un mélange de 4-hexadécyloxy- et de 4-stéaryloxy-2,2,6,6-tétraméthylpipéridine ; un condensat de N,N'-bis(2,2,6,6-tétraméthylpipéridin-4-yl)hexaméthylènediamine et de 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine ; un condensat de 1,2-bis(3-aminopropylamino)éthane, de 2,4,6-trichloro-1,3,5-triazine et de 4-butylamino-2,2,6,6-tétraméthylpipéridine ; 2-undécyl-7,7,9,9-tétraméthyl-1-oxa-3,8-diaza-4-oxospiro[4.5]décane ; oxo-pipérazinyl-triazines ; un produit de réaction du 7,7,9,9-tétraméthyl-2-cycloundécyl-1-oxa-3,8-diaza-4-oxospiro[4.5]décane et de l'épichlorhydrine ; butane-1,2,3,4-tétracarboxylate de tétrakis(2,2,6,6-tétraméthyl-4-pipéridyle) ; acide 1,2,3,4-butanetétracarboxylique, ester de tétrakis(1,2,2,6,6-pentaméthyl-4-pipéridinyle) ; acide 1,2,3,4-butanetétracarboxylique, ester de 1,2,2,6,6-pentaméthyl-4-pipéridinyle et de tridécyle ; acide 1,2,3,4-butanetétracarboxylique, ester de 2,2,6,6-tétraméthyl-4-pipéridinyle et de tridécyle ; acide 1,2,3,4-butanetétracarboxylique, polymère avec le 2,2,6,6-tétraméthyl-2,4,8,10-tétraoxaspiro[5.5]-undécane-3,9-diéthanol, ester de 1,2,2,6,6-pentaméthyl-4-pipérdinyle ; acide 1,2,3,4-butanetétracarboxylique, polymère avec le 2,2,6,6-tétraméthyl-2,4,8,10-tétraoxaspiro[5.5]-undécane-3,9-diéthanol, ester de 2,2,6,6-tétraméthyl-4-pipérdinyle ; carbonate de bis(1-undécanoxy-2,2,6,6-tétraméthylpipéridin-4-yle) ; 1-(2-hydroxy-2-méthylpropoxy)-2,2,6,6-tétraméthyl-4-pipéridinol ; 1-(2-hydroxy-2-méthylpropoxy)-4-octadécanoyloxy-2,2,6,6-tétraméthylpipéridine ; 1-(4-octadécanoyloxy-2,2,6,6-tétraméthylpipéridin-1-yloxy)-2-octadécanoyloxy-2-méthylpropane ; 1-(2-hydroxyéthyl)-2,2,6,6-tétraméthyl-4-pipéridinol ; un produit de réaction du 1-(2-hydroxyéthyl)-2,2,6,6-tétraméthyl-4-pipéridinol et du succinate de diméthyle ; 2,2,4,4-tétraméthyl-7-oxa-3,20-diazadispiro[5.1.11.2]hénicosan-21-one ; l'ester du 2,2,6,6-tétraméthyl-4-pipéridinol avec des acides gras d'ordre supérieur ; 3-dodécyl-1-(2,2,6,6-tétraméthyl-4-pipéridyl)pyrrolidine-2,5-dione ; 1H-pyrrole-2,5-dione, 1-octadécyl-, polymère avec le (1-méthyléthényl)benzène et la 1-(2,2,6,6-tétraméthyl-4-pipéridinyl)-1H-pyrrole-2,5-dione ; pipérazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-éthanediyl]]tris[3,3,5,5-tétraméthyl-; pipérazinone, 1,1',1"-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-éthanediyl]]tris[3,3,4,5,5-pentaméthyl- ; le produit de réaction du 7,7,9,9-tétraméthyl-2-cycloundécyl-1-oxa-3,8-diaza-4-oxospiro[4.5]décane et de l'épichlorhydrine ; le condensat de la N,N'-bis(2,2,6,6-tétraméthylpipéridin-4-yl)hexaméthylènediamine et de la 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine ; le condensat du 1,2-bis(3-aminopropylamino)éthane, de la 2,4,6-trichloro-1,3,5-triazine et de la 4-butylamino-2,2,6,6-tétraméthylpipéridine ; le condensat de la N,N'-bis(2,2,6,6-tétraméthylpipéridin-4-yl)hexaméthylènediamine et de la 4-morpholino-2,6-dichloro-1,3,5-triazine ; le condensat de la 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tétraméthylpipéridyl)-1,3,5-triazine et du 1,2-bis(3-aminopropylamino)éthane ; le condensat de la 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentaméthylpipéridyl)-1,3,5-triazine et du 1,2-bis-(3-aminopropylamino)éthane ; 2-[(2-hydroxyéthyl)amino]-4,6-bis[N-(1-cyclohexyloxy-2,2,6,6-tétraméthylpipéridin-4-yl)butylamino-1,3,5-triazine ; acide propanedioïque, ester de [(4-méthoxyphényl)-méthylène]-bis-(1,2,2,6,6-pentaméthyl-4-pipéridinyle) ; 1,2,3,4-butanetétracarboxylate de tétrakis(2,2,6,6-tétraméthylpipéridin-4-yle) ; acide benzènepropanoïque, 3,5-bis(1,1-diméthyléthyl)-4-hydroxy-, ester de 1-[2-[3-[3,5-bis(1,1-diméthyléthyl)-4-hydroxyphényl]-1-oxopropoxy]éthyl]-2,2,6,6-tétraméthyl-4-pipéridinyle ; N-(1-octyloxy-2,2,6,6-tétraméthylpipéridin-4-yl)-N'-dodécyloxalamide ; nitrilotriacétate de tris(2,2,6,6-tétraméthylpipéridin-4-yle) ; acide 1,5-dioxaspiro{5,5}undécane-3,3-dicarboxylique, bis(1,2,2,6,6-pentaméthyl-4-pipéridinyle) ; acide 1,5-dioxaspiro{5,5}undécane-3,3-dicarboxylique, bis(2,2,6,6-tétraméthyl-4-pipéridinyle) ; le condensat de la 1-(2-hydroxyéthyl)-2,2,6,6-tétraméthyl-4-hydroxypipéridine et de l'acide succinique ; le condensat de la N,N'-bis(2,2,6,6-tétraméthylpipéridin-4-yl)hexaméthylènediamine et de la 4-tert-octylamino-2,6-dichloro-1,3,5-triazine ; acide 1,2,3,4-butanetétracarboxylique, ester de 1,2,2,6,6-pentaméthyl-4-pipéridinyle et de tridécyle ; 1,2,3,4-butanetétracarboxylate de tétrakis(2,2,6,6-tétraméthylpipéridin-4-yle) ; acide 1,2,3,4-butanetétracarboxylique, ester de 2,2,6,6-tétraméthyl-4-pipéridinyle et de tridécyle ; 1,2,3,4-butanetétracarboxylate de tétrakis(1,2,2,6,6-pentaméthylpipéridin-4-yle) ; mélange d'ester de dodécyle d'acide 2,2,4,4-tétraméthyl-21-oxo-7-oxa-3.20-diazaspiro(5.1.11.2)-hénicosane-20-propanoïque et d'ester de tédradécyle de d'acide 2,2,4,4-tétraméthyl-21-oxo-7-oxa-3,20-diazaspiro(5.1.11.2)-hénicosane-20-propanoïque ; 1H,4H,5H,8H-2,3a,4a,6,7a,8a-hexazacyclopenta[def]fluorène-4,8-dione, hexahydro-2,6-bis(2,2,6,6-tétraméthyl-4-pipéridinyl)- ; polyméthyl[propyl-3-oxy(2',2',6',6'-tétraméthyl-4,4'-pipéridinyl)]siloxane ; polyméthyl[propyl-3-oxy(1',2',2',6',6'-pentaméthyl-4,4'-pipéridinyl)]siloxane ; copolymère de méthacrylate de méthyle avec l'acrylate d'éthyle et l'acrylate de 2,2,6,6-tétraméthylpipéridin-4-yle ; copolymère d'un mélange d'alpha-oléfines en C20 à C24 et de (2,2,6,6-tétraméthylpipéridin-4-yl)succinimide ; acide 1,2,3,4-butanetétracarboxylique, polymère avec le β,β,β',β'-tétraméthyl-2,4,8,10-tétraoxaspiro[5.5]undécane-3,9-diéthanol, ester de 1,2,2,6,6-pentaméthyl-4-pipéridinyle ; acide 1,2,3,4-butanetétracarboxylique, polymère avec le β,β,β',β'-tétraméthyl-2,4,8,10-tétraoxaspiro[5.5]undécane-3,9-diéthanol, copolymère d'ester de 2,2,6,6-tétraméthyl-4-pipéridinyle ; 1,3-benzènedicarboxamide, N,N'-bis(2,2,6,6-tétraméthyl-4-pipéridinyle ; 1,1'-(1,10-dioxo-1,10-décanediyl)-bis(hexahydro-2,2,4,4,6-pentaméthylpyrimidine ; éthanediamide, N-(1-acétyl-2,2,6,6-tétraméthylpipéridinyl)-N'-dodécyle ; formamide, N,N'-1,6-hexanediylbis[N-(2,2,6,6-tétraméthyl-4-pipéridinyle) ; D-glucitol, 1,3:2,4-bis-O-(2,2,6,6-tétraméthyl-4-pipéridinylidène)- ; 2,2,4,4-tétraméthyl-7-oxa-3,20-diaza-21-oxo-dispiro[5.1.11.2]hénicosane ; propanamide, 2-méthyl-N-(2,2,6,6-tétraméthyl-4-pipéridinyl)-2-[(2,2,6,6-tétraméthyl-4-pipéridinyl)amino]- ; acide 7-oxa-3,20-diazadispiro[5.1.11.2]hénicosane-20-propanoïque, 2,2,4,4-tétraméthyl-21-oxo-, ester de dodécyle ; acide N-(2,2,6,6-tétraméthylpipéridin-4-yl)-β-aminopropionique, ester de dodécyle ; N-(2,2,6,6-tétraméthylpipéridin-4-yl)-N'-aminooxalamide ; propanamide, N-(2,2,6,6-tétraméthyl-4-pipéridinyl)-3-[(2,2,6,6-tétraméthyl-4-pipéridinyl)amino]- ; mélange de 4-hexadécyloxy- et de 4-stéaryloxy-2,2,6,6-tétraméthylpipéridine ; 3-dodécyl-1-(1,2,2,6,6-pentaméthylpipéridin-4-yl)pyrrolidine-2,5-dione ; 3-dodécyl-1-(1-éthanoyl-2,2,6,6-pentaméthylpipéridin-4-yl)pyrrolidine-2,5-dione ; succinate de bis(2,2,6,6-tétraméthylpipéridin-4-yle) ; 3,5-di-tert-butyl-4-hydroxybenzylmalonate de bis(1,2,2,6,6-pentaméthylpipéridin-4-yl)-n-butyle ; nitrilotriacétate de tris(2,2,6,6-tétraméthylpipéridin-4-yle) ; 1,1'-(1,2-éthanediyl)bis(3,3,5,5-tétraméthylpipérazinone) ; 4-benzoyl-2,2,6,6-tétraméthylpipéridine ; 4-stéaryloxy-2,2,6,6-tétraméthylpipéridine ; 2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl)malonate de bis(1,2,2,6,6-pentaméthylpipéridyle) ; 3-n-octyl-7,7,9,9-tétraméthyl-1,3,8-triazaspiro[4.5]décan-2,4-dione ; sébacate de bis(1-octyloxy-2,2,6,6-tétraméthylpipéridyle) ; succinate de bis(1-octyloxy-2,2,6,6-tétraméthylpipéridyle) ; 8-acétyl-3-dodécyl-7,7,9,9-tétraméthyl-1,3,8-triazaspiro[4.5]décane-2,4-dione ; 3-dodécyl-1-(2,2,6,6-tétraméthylpipéridin-4-yl)pyrrolidin-2,5-dione ; 3-dodécyl-1-(1-éthanoyl-2,2,6,6-tétraméthylpipéridin-4-yl)pyrrolidin-2,5-dione ; 3-dodécyl-1-(1,2,2,6,6-pentaméthylpipéridin-4-yl)pyrrolidine-2,5-dione ; un mélange de 4-hexadécyloxy- et de 4-stéaryloxy-2,2,6,6-tétraméthylpipéridine ; 2-undécyl-7,7,9,9-tétraméthyl-1-oxa-3,8-diaza-4-oxospiro[4.5]décane ; acide 1,5-dioxaspiro{5,5}undécane-3,3-dicarboxylique, bis(2,2,6,6-tétraméthyl-4-pipéridinyle) et acide 1,5-dioxaspiro{5,5}undécane-3,3-dicarboxylique, bis(1,2,2,6,6-pentaméthyl-4-pipéridinyle) ; N1-(β-hydroxyéthyl)3,3-pentaméthylène-5,5-diméthylpipérazin-2-one ; N1-tert-octyl-3,3,5,5-tétraméthyl-diazépin-2-one ; N1-tert-octyl-3,3-pentaméthylène-5,5-hexaméthylène-diazépin-2-one ; N1-tert-octyl-3,3-pentaméthylène-5,5-diméthylpipérazin-2-one ; trans-1,2-cyclohexane-bis-(N1-5,5-diméthyl-3,3-pentaméthylène-2-pipérazinone ; trans-1,2-cyclohexane-bis-(N1-3,3,5,5-dispiropentaméthylène-2-pipérazinone) ; N1-isopropyl-1,4-diazadispiro-(3,3,5,5)pentaméthylène-2-pipérazinone ; N1-isopropyl-1,4-diazadispiro-3,3-pentaméthylène-5,5-tétraméthylène-2-pipérazinone ; N1-isopropyl-5,5-diméthyl-3,3-pentaméthylène-2-pipérazinone ; trans-1,2-cyclohexane-bis-N1-(diméthyl-3,3-pentaméthylène-2-pipérazinone) ; N1-octyl-5,5-diméthyl-3,3-pentaméthylène-1,4-diazépin-2-one ; et N1-octyl-1,4-diazadispiro-(3,3,5,5)pentaméthylène-1,5-diazépin-2-one.
     
    13. Utilisation selon la revendication 10, dans laquelle le photostabilisant est un absorbeur de lumière ultraviolette choisi parmi une 2-hydroxybenzophénone, un 2-(2'-hydroxyphényl)benzotriazole, une 2-(2'-hydroxyphényl)-1,3,5-triazine, et les combinaisons de ceux-ci.
     
    14. Utilisation selon la revendication 13, dans laquelle l'absorbeur de lumière ultraviolette est une 2-(2'-hydroxyphényl)-1,3,5-triazine répondant à la Formule (VII) :

    dans laquelle chacun des radicaux R34 et R35 est indépendamment choisi parmi un aryle en C6-C10 éventuellement substitué, un amino substitué par hydrocarbyle en C1-C10, un acyle en C1-C10 ou un alkoxyle en C1-C10 ; et dans lequel R36 représente un substituant qui est identique ou différent en entre 0 et 4 positions de la portion phénoxy de Formule VII et est indépendamment choisi parmi un hydroxyle, un hydrocarbyle en C1-C12, un alkoxyle en C1-C12, un alkoxyester en C1-C12, ou un acyle en C1-C12.
     
    15. Utilisation selon la revendication 13 ou la revendication 14, dans laquelle la 2-(2'-hydroxyphényl)-1,3,5-triazine est choisie parmi : 4,6-bis-(2,4-diméthylphényl)-2-(2-hydroxy-4-octyloxyphényl)-s-triazine ; 4,6-bis-(2,4-diméthylphényl)-2-(2,4-dihydroxyphényl)-s-triazine ; 2,4-bis(2,4-dihydroxyphényl)-6-(4-chlorophényl)-s-triazine ; 2,4-bis[2-hydroxy-4-(2-hydroxy-éthoxy)phényl]-6-(4-chlorophényl)-s-triazine ; 2,4-bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-éthoxy)phényl]-6-(2,4-diméthylphényl)-s-triazine ; 2,4-bis[2-hydroxy-4-(2-hydroxyéthoxy)phényl]-6-(4-bromophényl)-s-triazine ; 2,4-bis[2-hydroxy-4-(2-acétoxyéthoxy)phényl]-6-(4-chlorophényl)-s-triazine ; 2,4-bis(2,4-dihydroxyphényl)-6-(2,4-diméthylphényl)-s-triazine ; 2,4-bis(4-biphénylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)éthylidèneoxy]phényl]-s-triazine ; 2,4-bis(4-biphénylyl)-6-[2-hydroxy-4-(2-éthylhexyloxy)phényl]-s-triazine ; 2-phényl-4-[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)phényl]-6-[2-hydroxy-4-(3-sec-amyloxy-2-hydroxypropyloxy)phényl]-s-triazine ; 2,4-bis(2,4-diméthylphényl)-6-[2-hydroxy-4(3-benzyloxy-2-hydroxypropyloxy)phényl]-s-triazine ; 2,4-bis(2-hydroxy-4-n-butyloxyphényl)-6-(2,4-di-n-butyloxyphényl)-s-triazine ; 2,4-bis(2,4-diméthylphényl)-6-[2-hydroxy-4-(3-nonyloxy-2-hydroxypropyloxy)-5-α-cumylphényl]-s-triazine ; méthylène bis-{2,4-bis(2,4-diméthylphényl)-6-[2-hydroxy-4-(3-butyloxy-2-hydroxypropoxy)phényl]-s-triazine} ; mélange de dimères pontés par méthylène pontés aux positions 3:5', 5:5' et 3:3' dans un rapport 5:4:1 ; 2,4,6-tris(2-hydroxy-4-isooctyloxycarbonyliso-propylidèneoxy-phényl)-s-triazine ; 2,4-bis(2,4-diméthylphényl)-6-(2-hydroxy-4-hexyloxy-5-α-cumylphényl)-s-triazine ; 2-(2,4,6-triméthylphényl)-4,6-bis[2-hydroxy-4-(3-butyloxy-2-hydroxypropyloxy)phényl]-s-triazine ; 2,4,6-tris[2-hydroxy-4-(3-sec-butyloxy-2-hydroxypropyloxy)-phényl]-s-triazine ; mélange de 4,6-bis-(2,4-diméthylphényl)-2-(2-hydroxy-4-(3-dodécyloxy-2-hydroxypropoxy)phényl)-s-triazine et de 4,6-bis-(2,4-diméthylphényl)-2-(2-hydroxy-4-(3-tridécyloxy-2- hydroxypropoxy)phényl)-s-triazine ; 4,6-bis-(2,4-diméthylphényl)-2-(2-hydroxy-4(3-(2-éthylhexyloxy)-2-hydroxypropoxy)-phényl)-s-triazine ; 4,6-diphényl-2-(4-hexyloxy-2-hydroxyphényl)-s-triazine ; 2-(4,6-diphényl-1,3,5-triazin-2-yl)-5-[2-(2-éthylhexanoyloxy)éthoxy]phénol ; 2,4,6-tris(2-hydroxy-4-octyloxyphényl)-1,3,5-triazine ; acide propanoïque, ester de 2,2',2"-[1,3,5-triazine-2,4,6-triyltris[(3-hydroxy-4,1-phénylène)oxy]]tris-1,1',1"-trioctyle ; acide propanoïque, ester de 2-[4-[4,6-bis([1,1'-biphényl]-4-yl)-1,3,5-triazin-2yl]-3-hydroxyphénoxyl]-isooctyle ; et leurs combinaisons.
     
    16. Utilisation selon la revendication 10, dans laquelle le photostabilisant est un photostabilisant de type amine encombrée et un absorbeur de lumière ultraviolette.
     
    17. Utilisation selon l'une quelconque des revendications 1 à 16, dans laquelle la composition de polymère comprend en outre au moins un composé choisi parmi les co-adjuvants ; les agents de nucléation ; les charges ; les agents de renfort ; les adjuvants polymères ; et les combinaisons de ceux-ci.
     
    18. Utilisation selon l'une quelconque des revendications 1 à 17, dans laquelle la composition de stabilisant est présente entre 0,001 % et 65,0 % en masse par rapport à la masse totale de la composition de polymère ; préférentiellement entre 0,01 et 25 % en masse par rapport à la masse totale de la composition de polymère ; et plus préférentiellement entre 0,01 et 10 % en masse par rapport à la masse totale de la composition de polymère.
     




    Drawing












    REFERENCES CITED IN THE DESCRIPTION



    This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

    Patent documents cited in the description




    Non-patent literature cited in the description